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SUMMARY
Drug metabolism in rat and mouse skin was investigated using subcellular 
fractions and skin strips.
The a b ility  to homogenize skin and any resulting unwanted damage to 
organelles was investigated. Relatively mild homogenization conditions 
were eventually employed. A scheme of subcellular fractionation was 
carried out and microsomes harvested and some indication of the extent 
of contamination by other fractions obtained.
The chronology of the hair cycle in rat and mousewqs ascertained.
Drug metabolizing activ ities  at different phases of the hair cycle 
were investigated, but no major changes were observed.
The induction and inhibition of cutaneous cytochrome P-450 activ ities  
were investigated. The mouse had higher constitutive levels but the 
rat was the more responsive to inducers. Activities in both species 
were inhibited by benzoflavone isomers and metyrapone. The mouse 
was more sensitive to inhibition by various solvents than the ra t. 
Spectral and electrophoretic studies were also carried out.
UDP-Glucuronyltransferase activ ity  to 1-naphthol was shown to be 
present in rat and hairless mouse skin microsomes and was activated 
by detergents. The possibility of interference with the assay by 
other enzymes was checked. Apparent Km values were lower than those 
quoted for liv e r. Esterase activ ity  to indoxyl acetate was found in 
both microsomal and high speed supernatant fractions. Apparent Km 
values were much higher than those quoted for liv e r.
The distribution of enzyme activ ities  between the epidermis and 
dermis was investigated. There was some evidence for a d ifferentia l 
distribution of oxidation and conjugation reactions in mouse skin.
Deethylation, sulphation and glucuronidation activ ities  in ra t and 
hairless mouse skin strips were investigated. Induction of 
deethylation was shown and this resulted in changed patterns of 
metabolism in respect to the percentages of free and conjugated 
metabolites. Patterns of activ ity  and inducibility were similar to 
those observed in microsomes, except that the levels of induction 
were higher in the strips.
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C H A P T E R  1 
INTRODUCTION
1.1 STRUCTURE OF THE SKIN
1.1.1 Introduction
The skin envelopes the entire surface of the body and its  epithelium is 
continuous with that of the external orifices of the digestive, 
respiratory and urogenital systems. Among the functions of skin none 
is more important than preventing the organism from desiccating and 
protecting i t  from its  environment, while maintaining i t  in uninterrupted 
communication with the environment. Other functions are numerous and 
varied. The pelage and other structures that grow from the skin,
i
protect, warm, camouflage, or a ttract attention, and its  glands secrete 
substances that repel or attract and play an important role in the 
social and sexual aspects of the organism. The skin is a complex and 
v ita l organ and in its  exposed position its  a b ility  to interact with 
the external environment is of great importance. The skin has two main 
layers, the epidermis and dermis. Below the dermis is an adipose layer, 
sometimes referred to as the hypodermis. A diagramatic representation 
of skin is shown in Figure 1.1.
1.1.2 The Epidermis
Ever since Malpighii f ir s t  described i t ,  the epidermis has been divided 
into an inner layer of viable cells (stratum Mai phi ghi i ) and an outer 
one of anucleated horny cells (stratum corneurn). The stratum Malpighii 
is conventionally subdivided into a basal layer one-cell deep (stratum 
basale or stratum germinativum) in contact with the dermis, a spinous 
layer of variable thickness above i t  (stratum spinosum), and a 
granular layer (stratum granulosum) which contains various-sized kerato-
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FIGURE 1.1
Schematic Diagram of Mammalian Skin
HL : horny layer CF : collagen fib re  network
GL : granular layer HF : hair fo ll ic le
BL : basal layer SF : subcutaneous fa t
AP : arrector pi 1i muscle BV : blood vessel
SG : sebaceous gland EG : eccrine gland
hyalin granules. In addition, in fric tio n  surfaces or in areas where 
the epidermis is very thick, there is a hyalin layer (stratum lucidum).
Basal epidermal cells are cuboidal with the axis aligned vertica lly  
to the skin surface. Cell division occurs mainly in this layer. As 
the daughter cells are displaced toward the surface they become larger 
and polyhedral in shape. At higher levels they become progressively 
flattened in a plane parallel to the surface of the skin. The integrity  
of the epidermis is maintained by attachments called desmosomes.
Other cells found in the epidermis are melanocytes, Langerhan cells and
Merkel cells . Melanocytes are dendritic cells which are found sandwiched
between tightly  packed keratinocytes in the germinative layer. The only
known function of melanocytes is the synthesis of pigment granules
(melanosomes), the main component of which is a pigment called melanin.
Eventually, melanosomes are transferred to the surrounding keratinocytes.
I t  is not certain how this transfer is achieved but i t  is thought that
keratinocytes actively phagocytose the melanin-laden melanocyte dendrites.
Pigmentation depends on the rate of melanogenesis and the rate of transfer
of melanosomes from melanocytes into keratinocytes. I t  has been shown
250that neither sex nor race affect the number of melanocytes .
Another type of dendritic cell is seen in the upper layers of the
epidermis. These cells were f ir s t  described by Langerhans and were la ter
named after him. Functionally they were considered to be effete  
175melanocytes . However, their presence was demonstrated in the
epidermis of animals deprived of the neural crest from which melano- 
39cytes are derived . Another proposed function was as phagocytes, but
284experiments with peroxidase and fe rr it in  showed no phagocytic ac tiv ity
Throughout the epidermis and adjacent to certain hair fo llic le s  are 
discrete thickened regions called epidermal pads, ta c tile  discs or 
Hciar-scheiben. Scattered among the basal keratinocytes in these 
areas are certain apparently specialised cells , called Merkel ce lls , 
which because of their association with neural terminations are thought 
to be sensory receptors.
1.1.3 The Dermi s
The dermis, or corrium, lying between the epidermis and the subcutaneous 
panniculus, consists basically of a matrix of connective tissue composed 
of the fibrous proteins collagen, el astin and reticu lin , which are 
embedded in an amorphous ground substance. The dermal matrix contains 
few cells , with most of these in the upper papillary layer rather than 
in the lower reticulum layer. The cell types found are fibroblasts, 
macrophages, melanocytes and extravasated leukocytes.
Fibroblasts, under normal conditions the most numerous cells in connective 
tissue, are responsible for the formation of collagenous and e lastic  
fibres and the ground substance. Macrophages are ubiquitous in mammalian 
tissues. Dermal macrophages, which are typical of those in most tissues, 
are characterised by an eccentrically located indented nucleus. They 
have several important functions, related primarily to their phagocytic 
capability. As scavengers they dispose of foreign materials and degrade 
them and they also participate in the immune responses. Mast cells 
were discovered by Ehrlich and were so named because their cytoplasm 
is f il le d  with large metachromatic granules. They are ubiquitous in 
connective tissue and are often arranged around the walls of small blood 
vessels. The granules contain heparin, histamine and serotonin.
Degranulation can occur under both physical and chemical conditions
and participates in the in it ia l response of connective tissue to various
injuries.
1.1.4 Skin Appendages
1.1.4.1 The pi 11ary apparatus
Hairs consist of compactly cemented keratinised cells produced by fo llic le s . 
These fo llic le s , together with the sebaceous glands that grow from their 
sides, form what are known as pilosebaceous units. The hair shaft 
consists of an outer cuticle, a cortex, and a central medulla. The 
cuticle is a single layer of imbricated scales, with the free margins 
directed toward the tip  of the hair. Cuticle scales are translucent 
and nonpigmented. Inside the fo llic le  the cuticle cells are interlocked 
with those of the inner root sheath, an arrangement that firm ly anchors 
the hair in the fo ll ic le . Most hairs are composed chiefly of cortex.
In the cells of the cortex, melanin granules are aligned longitudinally 
in pigmented hairs. In the centre of a ll hair shafts, except the extremely 
fine ones, is a continuous or discontinous medulla, composed of large 
loosely connected keratinised cells .
Hair fo llic les  are composed of an outer and inner root sheath. The 
thickness of the outer sheath is proportional to the size of the hair 
fo ll ic le . The inner root sheath is composed of three concentric 
layers: Henle's layer on the outside is one cell thick and rests against 
the outer sheath; Huxley's layer, in the middle, is two or more cells  
thick; the single-layered cuticle of the inner sheath on the inside 
rests against the hair. The outer root sheath is separated from 
surrounding connective tissue by a hyalin, noncellular membrane. The
fo llic le s  attain their greatest diameter at their base, where they 
are dilated into an onion-shaped bulb. The bulb contains the loose 
connective tissue of the dermal papilla. In active fo llic le s  the 
dermal papilla is attached to the connective tissue sheath by a narrow 
basal stalk. Hair grows cyclically , with alternating periods of growth 
and quiescence. This aspect w ill be dealt with in greater detail in 
Chapter 4.
1.1.4.2 Sebaceous glands
Sebaceous glands consist of multiple aggregates of acini that empty 
into a duct that generally opens into the p illa ry  canal. Despite 
differences in size, shape or position, their cellu lar morphology and 
sequences of differentiation are sim ilar. Differentiation consists 
of the synthesis and accumulation of lip id  droplets which culminate 
in enlarged cells that fragment to form sebum. Each acinus is 
attached to a common excretory duct, composed of s tra tified  squamous 
epithelium, which is continuous with the wall of the p illa ry  canal.
As the acini develop, the cells enlarge centripetally . In the centre 
they are large, misshapen, or undergoing fragmentation, &t the outer 
periphery the undifferentiated cells resemble those of the epidermis. 
The centre of mature acini and the ducts contain a mixture of lipids  
and cell detritus.
1.1.4.3 Eccrine sweat glands
Eccrine sweat glands are simple tubes that extend from the epidermis 
to the dermis. Occasionally the terminal part of the duct branches 
and at other times the ducts of two adjacent glands fuse beneath the 
epidermis and deliver their contents to the surface through a common
duct. The course of the duct within the dermis is somewhat h e lica l.
Each tubule consists of a duct and a secretory segment, the la tte r  
roughly half the tubular length, which is irregularly and often 
tightly  coiled. There are two main cell types in the secretory elements, 
the dark and the clear cells . The clear cells account for the production 
of sweat. Analysis of the fine structure of the cytoplasm of dark 
cells revealed secretory organelles and droplets. The function and fate  
of their secretory product has not been established.
1.1.4.4 Apocrine glands
The apocrine glands are tubular glands consisting of a secretory coil 
embedded in the dermis and a duct that conveys secretory products to 
the pilosebaceous canal. These glands rarely respond to thermal 
stimulation ana their product should not be called sweat. They occur 
in a restricted distribution, which in man includes the external 
auditory canal, the a x illa , the areola, the pubis, and the perineum.
The secretory coil is lined with either cuboidal or columnar ce lls , the 
shape being variable and depending upon secretory ac tiv ity . The upper 
part of the secretory segment narrows abruptly and emerges into an 
extremely slender duct. The duct runs a re latively  straight course 
parallel to the hair fo llic le  and is composed of two layers of ce lls .
The glands secrete slowly and l i t t l e  is known about the composition 
or function of the secretion.
1.2 Drug Metabolism
1.2.1 Introduction
The body may be exposed, either accidentally or deliberately, to a diverse 
range of foreign compounds. These chemicals may enter the body via the 
gastrointestinal tract, the lungs, or the skin. The majority of these 
compounds then undergo some degree of transformation, with few substances 
being excreted unchanged. While purely chemical reactions do occur, 
for example hydrolysis in the acidic environment of the stomach, foreign 
compounds in general act as substrates for a series of enzymes present 
in the tissues. The metabolites formed are usually less lip id  soluble 
than the parent compound, making them more readily excreted and less 
able to penetrate lipoidal barriers. H istorically these enzymes were 
regarded as detoxifying enzymes, but in certain cases metabolism leads 
to an enhancement of toxicity or pharmacological potency.
The different types of biotransformations nave been classified into 
two groups, phase I (nonsynthetic) reactions, which may involve 
oxidation, reduction or hydrolysis, and phase I I  (synthetic) reactions 
which involve interaction of a drug or metabolite with endogenous 
compounds, such as glucuronic acid. One compound may be a potential 
substrate for a number of competing pathways of metabolism. The liv e r  
has trad itionally been regarded as the principal site of foreign compound 
metabolism, however, accumulating evidence indicates that metabolism 
of foreign compounds can occur in a wide variety of tissues.
Only the enzyme systems of relevance to this study, or that have been 
shown to be present in skin w ill be described here.
1.2.2 Mixed Function Oxidases
1.2.2.1 Cytochrome P-450
(a) General
Cytochrome P-450 is known to be a component of many mixed function
oxidase reactions in the metabolism of steroids, fa tty  acids and
foreign compounds in vertebrate tissues. Metabolism is achieved by
the reduction and activation of molecular oxygen by a two electron 
89transfer . The mechanism is considered to entail the reduction of a
3+cytochrome P-450 (Fe ) -substrate complex via a reduced flavoprotein
(NADPH)-cytochrome P-450 reductase. The complex then interacts with
molecular oxygen, thus giving rise to a ternary reduced cytochrome
P-450 (Fe^+)-substrate-oxygen complex. The complex accepts a second
electron from an unknown donor with the formation of an unidentified
active oxygen-cytochrome P-450-substrate complex. Immunological and
spectral evidence suggest that the second reducing equivalent may be
supplied by cytochrome b^^. After transfer within the complex of
one oxygen atom and the uptake of a proton, the complex dissociates
3+into oxidized cytochrome P-450 (Fe ) , water and oxidized product.
Optical studies of hepatic cytochrome P-450 using the technique of
difference spectrophotometry, have shown that addition of a variety of
substrates to liver microsomes results in a series of perturbations
ascribed to modifications in the environment of the haem iron of 
227cytochrome P-450 . The type I spectral change is implicated in the
manifestation of the enzyme-substrate complex, although i t  can 
also be produced by non-substrates. This interaction is thought to 
be with the apoprotein. The type I I  spectral change is due to the r 
formation of a ferrihaemochrome, indicating a direct reaction between
a compound and the haem iron. Compounds which give rise to a type I I
spectrum only are often metabolized poorly, i f  at a l l ,  by cytochrome
P-450. The reverse type I spectral change can be caused by both
substrates and non-substrates. There have been a number of explanations
as to the cause of this type of interaction. These include displacement
234of endogenously bound substances , binding to the apoprotein, and a
288haem-ligand interaction
In live r the fact that multiple species of cytochrome P-450 exist and
that these various types of cytochrome P-450 respond d ifferently  when
an animal is exposed to various inducing agents, is now well established.
The evidence for this m ultip lic ity  has been gained from studies on drug
induced changes in the microsomal protein pattern, as determined by
fi 12 6gel electrophoresis 5 , as well as the a b ility  to isolate and purify
various cytochrome P-450 with differing physical and biochemical 
127 139properties * and by the reconstitution of mixed function oxidase 
systems with d istinct, but overlapping, patterns of substrate 
s p e c ific ity ^ 9^ .  The two classical types of inducer are the pheno- 
barbitone and poly cyc lic  hydrocarbon (3-methylcholanthrene) types.
Other compounds thought to induce different forms of hepatic cytochrome
82 50 207P-450 are safrole , acetamidofluorine , ethanol , and pregnenolone-
16916a-carbonitrile . 3-Methylcholanthrene is considered to be more 
effective than phenobarbitone in most extrahepatic tissues, but the 
a b ility  of the other inducers mentioned to induce in extrahepatic tissues 
has been only sparsely reported.
(b) Skin cytochrome P-450
Attempts to measure the carbon monoxide cytochrome P-450 complex 
spectrophotometrically in skin microsomes have met with very limited  
success. Two major problems which have been encountered, apart from the
the very low levels of cytochrome P-450, are the presence of cytochrome
oxidase and of cytochrome P-420. Cytochrome oxidase exhibits an
absorption minimum at 444 nm under the cytochrome P-450 assay conditions
and has been reported to interfere with cytochrome P-450 measurement
215in mouse skin microsomes . I t  seems like ly  that the extent of this 
problem w ill depend on the nature of the homogenization procedure and 
in particular its  a b ility  to disrupt mitochondria.
Cytochrome P-420 is another unwanted haemoprotein. Hepatic cytochrome
P-420 has different spectral and electron paramagnetic resonance (EPR)
properties from cytochrome P-450. The EPR signals of oxidised hepatic
cytochrome P-450 are attributed to the -S’ ligand of a cysteinyl residue 
210of the apoprotein . I t  has been proposed that when one of the ligands
is replaced by an a r t if ic ia l chemical or other amino acid residues of
the protein in the course of denaturation, cytochrome P-450 is converted
210into cytochrome P-420, with subsequent changes in the EPR signal
A wide range of reagents have been shown to cause the conversion of
287hepatic cytochrome P-450 to cytochrome P-420 . A peak at 420 nm,
thought to represent cytochrome P-420, has been found to be present 
in higher amounts than cytochrome P-450 in microsomes prepared from
0C\ onn one
control and induced mouse skin 9 9 . A variety of compounds have
been added to the homogenization medium in an attempt to protect
215cytochrome P-450 from degradation . These included benzphetamine,
2,3,7,8-tetrachlorodibenzo-j3-dioxan, testosterone and d ith io th re ito l.
None decreased the peak at 420 nm. Greater success in countering the
cytochrome P-420 problem appears to have been achieved by resuspending
the microsomal pellet in 30% glycerol . The peak at 420 nm has not
definitely been proved to be cytochrome P-420 and even i f  i t  is there
is the possibility that i t  may be also present in vivo. Spectra
215obtained from intact mouse skin showed a peak at 420 nm . This problem
of possible breakdown of cytochrome P-450 is of importance and there 
is an obvious need for further study in this area.
Three cytochrome P-450 dependent reactions, using model substrates,
have been reported to occur in skin preparations. These are benzo(a)-
pyrene hydroxylase, 7-ethoxycoumarin deethylase and aniline hydroxylase.
Benzo(a)pyrene hydroxylase, or aromatic hydrocarbon hydroxylase (AHH)
as i t  is often called, has been the most studied cytochrome P-450
dependent activ ity  in skin. Most of the studies have used a fluorescence
assay which supposedly measures the fluorescence of 3-hydroxybenzo(a)-
pyrene, but in fact measures the total fluorescence of a number of
metabolites of which 3-hydroxybenzo(a)pyrene is the major one. AHH from
2 255mouse skin is dependent on NADPH 5 and is inhibited by carbon
275 2monoxide . NADH exhibits a synergistic action with NADPH . AHH has
been shown to be inducible in ra t, mouse and human skin. Some of the 
inducers that have been used and shown to be effective are summarised 
in table 1.1. A study on the effectiveness of polycyclic hydrocarbons, 
when applied topically, to induce AHH showed that unsubstituted poly­
cyclic hydrocarbons are in general better inducers than substituted 
275ones . The a b ility  to induce did not correlate with their a b ility
105to in itia te  tumours in mouse skin. Addition of 7,8-benzoflavone ,
\
o es trio l^  and testosterone^ to the enzyme assay inhibited both 
constitutive and induced AHH in mouse skin homogenates. I t  has been 
shown that the level of activ ity  of the hepatic microsomal hydroxylase 
is influenced by factors such as age, sex, hormones and nu tritio n ^  s^ .  
Although there is presently very l i t t l e  data, i t  appears lik e ly  that 
the cutaneous enzyme is affected by similar influences. I t  has been 
reported that mice kept on a riboflavin-deficient diet for 4 weeks showed 
a 25% reduction in skin AHH. After supplementation with the vitamin, 
basal and 7,12-dimethylbenzanthracene induced enzyme levels rose above
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56those of mice kept on a control diet . AHH in the skin of castrated
male mice exhibited no change in levels of constitutive or induced AHH
194after hormone implantation . More intensive investigations of 
benzo(a)pyrene metabolism by skin preparations have been carried out 
using HPLC techniques. Incubation with homogenates from control mice 
resulted in the detection of phenolic compounds (3- and 9-hydroxy- 
benzo(a)pyrene) only. 3-Methylcholanthrene pretreatment resulted in
22the detection also of the 4 ,5 -d io l, 7 ,8 -d io l, 9,10-diol and 1,6-quinone .
Incubation with cell cultures of human epithelial cells produced
appreciable amounts of 9 ,10-diol, 1 ,6 -, 3 ,6 -, 6,12-quinone and 3- and
959-hydroxy derivatives. Notable by its  absence was the 4,5-diol .
7-Ethoxycoumarin deethylase activ ity  has been shown to be present in
microsomes prepared from mouse skin and to be inducible by topical
application of TCDD, whereas 3-methylcholanthrene had no apparent 
215effect . In rat skin microsomes the constitutive activ ity  was non- 
detectable but was detectable after treatment with hexachlorobenzene 
for 70 days, which also induced experimental po rp hyria^ .
Aniline hydroxylase activ ity  has been reported in microsomes prepared 
215from mouse skin . No induction experiments have been reported.
Whether this represents a cytochrome P-450 dependent reaction is unclear
as i t  has been shown that haemoproteins and flavins can achieve
249considerable rates of activ ity  . Aniline hydroxylase in the rat and
human placenta is in large part due to the catalytic activ ity  of
148contaminating haemoglobin with NADPH as the electron donor .
Therefore, aniline hydroxylase is an inadvisable choice for study of 
monooxygenase, activ ity  in an undefined system such as skin..
1.2.2.2 Mixed function amine oxidase
(a) General
Prior to 1962, cytochrome P-450 was generally considered the enzyme
solely responsible for the biological oxidation of nitrogen in organic
compounds^. However, in 1962 a report^ suggested that t r i  methyl amine
may be N-oxidised by an enzyme other than cytochrome P-450. Subsequently
i t  has been demonstrated that a flavoprotein is capable of carrying out
177 213mixed function oxidation of amines and sulphur-containing compounds 5
In contrast to cytochrome P-450, induction of amine oxidase by pretreating
animals with drugs has not been demonstrated^. Hepatic ac tiv ity  does,
258however, change markedly during the l i fe  cycle of rodents . The
oxidase purified to homogeneity from hog live r contains approximately
29315 nmoles FAD per milligram of protein . Using SDS polyacrylamide
gel electrophoresis a minimum molecular weight of 65,000 has been
calculated, however the sedimentation rate of the native enzyme
suggests that the enzymically active species exists as an octomer in
293equilibrium with small quantities of tetrameric forms . The purified
293oxidase appears free from metals, haem and lip id
Cysteamine, the decarboxylated metabolite of cysteine, may be a
physiological substrate for this enzyme, and i t  is specifically
218oxidised to the disulphide cystamine . I t  has been postulated that
this reaction may be a source of disulphide for synthesis of protein 
292disulphide bonds and there is evidence that this reaction can support
renaturation of reduced ribonuclease in the presence of glutathione
218and glutathione reductase
(b) Skin
This enzyme has not been investigated in skin. However, i f  this enzyme
is involved in disulphide bond formation, the large amounts of cysteine
182in the keratins of the epidermis and hair would suggest that 
appreciable amounts of this enzyme may be present.
1.2.3 Esterases
(a) General
The esterases are a very heterogeneous group of enzymes. Below are 
outlined several of the major clashes of esterases, although i t  is 
possible for some activ ities  to possess some of the characteristics 
of one or more of these classes.
Acetyl cholinesterase (true cholinesterase) plays an important role
in the hydrolysis of acetylcholine in nervous tissue. I t  appears to
be intimately involved in the neurohumoral functions of acetylcholine
159in nerve transmission and in nerve conduction
Carbonic anhydrase is found primarily in erythrocytes and appears to
aid the diffusion or transport of carbon dioxide, hydrogen ions,
75bicarbonate, and sodium ions . I t  also has the a b ility  to catalyse
252the hydrolysis of the acetate and butyrate esters of 1- and 2-naphthol 
Human erythrocytes have at least three forms of carbonic anhydrase.
Cholinesterases (pseudocholinesterases) catalyse the hydrolysis of many
of the same choline esters as acetyl cholinesterase. In addition,
cholinesterase catalyses the hydrolysis of benzoyl choline, procaine,
151acetyl salicylate and succinylcholine . Cholinesterases have an 
absolute requirement for divalent cations and are very sensitive to 
eserine.
Aliesterases (B-esterases) are characterised by the fact that they 
catalyse the hydrolysis of both aliphatic and aromatic esters, but 
not choline esters. They are distinguished from lipases by their selective 
action on water soluble substrates rather than water insoluble substrates, 
such as esters of glycerol and long chain fa tty  acids. They are
1 fi 1
inhibited by organophosphates but not by eserine
Arylesterases (aromatic esterases) preferentially catalyse the hydrolysis
of aromatic esters but not choline esters. Among the aromatic esters
there is a further preference for esters of acetic acid. There is a
requirement for a double bond on the alcohol moiety that must be in a
position alpha to the ester linkage. Thus aliphatic esters, such as
vinyl acetate with a double bond in the correct position, are also
13hydrolysed by arylesterase . They are not inhibited by organo- 
phosphate and eserine but are strongly inhibited by £-chloromercuri- 
benzoate.
Relatively l i t t l e  is known of the C-esterases. They can catalyse the 
hydrolysis of aliphatic and aromatic acetates and are distinguished
from arylesterase by being activated by organic mercurials at low
-5 49 -concentrations (10 M). They are not inhibited by organophosphates .
(b) Skin esterases
Several histochemical studies, using either 1-naphthyl acetate or
ID 93 1indoxyl acetate as substrates, have been reported 9 9 . Activity
was spread throughout the skin in the epidermis, sebaceous glands,
hair fo llic le s , and sweat glands. A study of the hydrolysis of
2-naphthyl acetate in guinea pig skin cell free preparations has been 
fifireported . The pH optimum was between 7.5 and 8.5 and the ac tiv ity  
was inhibited by propanolol. . The Km was seen to vary with skin
from different parts of the body, with values of 500-800 juM for the 
flank to 2000 jiM for the ear and 4000 pM for the hind foot pad.
Choi inesterase activ ity  has been shown to be present in human skin cell
172free preparations. Studies using different choline esters and
C-J
kinetic investigation of the hydrolysis of acetyl choline have led 
to the conclusion that both true and pseudocholinesterase are present.
1.2.4 Epoxide Hydratase
(a) General
Hepatic microsomal epoxide hydratase catalyses the hydration of a wide
variety of epoxides to the corresponding trans-dihydrodiols. The enzyme
has a very broad substrate specific ity , but most attention has been paid
to the hydrolysis of epoxides formed from polycyclic hydrocarbons. Data 
150 203from human and rat live r suggests there is only one type of micro­
somal enzyme. Epoxide hydratase is generally inducible along with
cytochrome P-450, but although the two enzymes are apparently closely
202related they are under separate genetic control . Epoxide hydratase
ICO
from rat live r has been purified to apparent homogeneity . I t  has
S
a minimum molecular weight of 53000-54000 and contains no haem or 
flav in , but small amounts of lip id . A different epoxide hydratase
has been reported to be present in the soluble fraction. This
5
catalysed the hydration of a C-jg insect juvenile hormone and synthetic 
121analogues
(b) Skin epoxide hydratase
Epoxide hydratase, analogous to the hepatic microsomal enzyme, has been
204 205 205 219 205shown to be present in rat 9 , mouse 9 and human skin. The
levels are low and in a study of 26 rat organs and tissues, skin had
the lowest activ ity  . Investigation of six K-region epoxides of poly-
cyclic hydrocarbons showed that skin could hydrate them and the specific
205activ ity  between species decreased in the order of human>mouse>rat .
Mouse skin epoxide hydratase has been reported to be enhanced by the
in vitro addition of 17&-oestradiol, 5,6-benzoflavone and 7,8-benzoflavone
55and also by treatment of animals with u ltravio let ligh t . The activ ities
o n e  2?
in human and mouse skin are inhibited by trichloropropane oxide 
and cyclohexane oxide.
1.2.5 UDP-Glucuronyltransferase
(a) General
Uridine-5'-diphospho-D-glucuronic acid (UDPGA) functions as the donor to
a variety of substrates to form glycosidically linked conjugates, commonly
referred to as glucuronides. This reaction is catalysed by UDP-glucuronyl
transferase. In glucuronide formation, the glucuronyl residue replaces
hydrogen from any of four main chemical groups that may be present on the
aglycone, hydroxyl, carboxyl, sulphydryl and amino or imino. In general
glucuronyltransferase is found predominantly in the microsomes, though
some activ ity  towards certain steroid substrates is associated with the
outer mitochondrial membrane in preparations derived from the gastro­
l l  6aintestinal tract
There is a lo t of indirect evidence that there are multiple forms of
hepatic glucuronyltransferase. This is based on evidence from
developmental patterns, induction, activation and kinetics . The
most convincing evidence comes from separation and purification of
different types of glucuronyltransferase. Activity towards 4-nitrophenol
80has been separated from activ ity  towards morphine in the ra t and 
79 27morphine and oestrone in the rabbit. Activity towards 1-naphthol
30has also been separated from that to morphine in the rat . Bock
has separated two enzymes associated with either 3-methylcholanthrene
32 33or phenobarbitone inducible activ ities  9 .
(b) Skin UDP-glucuronyltransferase
Cutaneous glucuronidation activ ity  was f ir s t  reported using isolated
294rat skin with 2-ami nophenol as substrate . Glucuronides of metabol­
ites of benzo(a)pyrene and of 3-hydroxybenzo(a)pyrene were extracted
from mouse skin homogenates a fter topical application of these 
123 124compounds 9 . Dutton reported the glucuronidation of 2-ami nophenol
87in skin strips from mice and guinea pigs and that pretreatment of
mice by topical application of benzo(a)pyrene led to an 80$ increase
248in activ ity  in the 1-4 day period after a single application y
Glucuronidation has been studied in cultures of human skin epithelia l
230cells and fibroblasts ; substrates used were 4-nitrophenol, 4-amino- 
phenol and b ilirub in . The a b ility  to form glucuronides was found 
with 4-nitrophenol and 4-ami nophenol, but not bilirubin in the epithelia l 
cells and was non-detectable with any of the substrates examinedrin 
the fibroblasts. The rate of glucuronidation by the epithelia l cells  
in culture was found to be similar to that of homogenates of the same 
cells supplemented with UDPGA. The rate of glucuronidation was not 
increased by preincubation of the cells with benzanthracene or benzo(a)- 
pyrene. Digitonin did not increase activ ity  when added to homogenates 
of the cells. I t  is possible that under the cell culture conditions 
and homogenate preparation, maximal induction and activation of 
glucuronyltransferase activ ity  had already occurred.
1.2.6 Sulphotransferases
(a) General
The soluble sulphotransferases are a group of enzymes which catalyse 
the transfer of sulphate from adenosine-3'-phosphate-51-phosphosulphate 
(PAPS) to alcohol or phenolic functional groups and some aromatic 
amines. At least three distinct sulphotransferases are believed to 
exist in mammalian tissues, which include those with activ ity  for 
phenols, tyrosine methyl ester and oestrone^. P artia lly  purified  
phenol sulphotransferases from the livers of ra ts ^ 0 and guinea pigs^  
have been obtained free of activ ity  towards certain steroids. Recently
two phenol sulphotransferases from rat liv e r have been purified to
238homogeneity . Each enzyme had a molecular weight of approximately
23865,000 and consisted of two subunits . They were similar with 
respect to substrate specificity and kinetic parameters, but differed  
in amino acid composition.
(b) Skin sulphotransferases
No reports have yet demonstrated convincingly that sulphation of 
foreign compounds occurs in skin. Trace amounts of a metabolite 
possessing the physical properties of a sulphated benzo(a)pyrene 
metabolite were extracted after topical application of benzo(a)pyrene
ncc
but the small amounts present prevented unequivocal identification
However, the sulphation of the steroids dehydroepiandrosterone and
5 20 9D
A  -androstene-33,173-diol by human skin has been reported * .
Although l i t t l e  is known about sulphation of foreign compounds, the skin
78is known to sulphate certain glycosaminoglycans . The principal 
sulphated glycosaminoglycans found in skin are chondroitin sulphate B 
(dermatan sulphate) and chondroitin sulphate A and C. A p artia lly
purified sulphotransferase which exhibited an acceptor specificity
74for dermatan has been isolated from rabbit skin . In contrast to the 
enzymes involved in sulphation of foreign compounds, which are usually 
soluble, the enzymes associated with the sulphation of glycosaminoglycans 
are of microsomal o rig in ^ .
1.2.7 Glutathione-S-transferases
(a) General
Glutathione-S-transferases are soluble enzymes that catalyse the conjugati
of glutathione with many foreign compounds that bear a suffic iently
61electrophilic carbon and have a hydrophobic nature . Glutathione
conjugations are thought to be metabolised further by cleavage of
the glutamate and glycine residues, followed by acetylation of the •
resultant free amino group of the cyteinyl residue to produce the final
36product, a mercapturic acid . The glutathione transferases are also
involved in the glutathione dependent formation of cyanide from thio- 
151cyanate ; the formation of n itr ite  from such organic n itrate  esters 
as t r in it ro g ly c e ro l^ ; the isomerisation of A 5 to A^-3-ketosteroids^;
1 CO
and a number of disulphide interchange reactions . They also act as
intracellu lar binding proteins for a large number of lipophilic
153compounds, including bilirubin
There are multiple forms of these enzymes and at least seven distinct 
transferases have been isolated from rat liv e r, and have been designated 
AA, A, B, C, D, E and M on the basis of the reverse order in which they 
elute from carboxymethylcellulose c o l u m n s ^ T h e s e  proteins 
are dimers with molecular weights of around 45,000 and have broad over­
lapping substrate s p e c if ic it ie s ^ . Both phenobarbitone and
1883-methylcholanthrene induced activ ities  in rat liv e r ' , with trans­
ferase B being induced more specifically with 3-methylcholanthrene 
than phenobarbitone^9.
(b) Skin glutathione-S-transferases
There has been only one report claiming direct evidence of the formation
of glutathione conjugates in skin. Activity to styrene oxide and
3-methylcholanthrene-11,12-oxide was demonstrated in the skin from six
190mouse strains and human foreskin . Styrene oxide showed the greater 
activ ity  and mouse skin had a higher activ ity  with both substrates 
than human skin. The enzyme was not inducible in skin by prior 
administration of 3-methylcholanthrene to mice. There are reports 
of indirect evidence for the a b ility  of skin to form glutathione 
conjugates. Bromobenzene6  ^ and some polycyclic hydrocarbons^9 have 
been shown to reduce the glutathione content of skin after topical 
application of these compounds.
1.3 PASSAGE OF DRUGS THROUGH THE SKIN
1.3.1 Percutaneous Absorption
The two major layers of the skin act as different types of barrier.
The dermis, the less effective barrier, w ill le t most solutes pass 
257readily while the epidermis, the major barrier, being of a lip id
nature w ill tend to exclude lipid-insoluble molecules while le tting
265the lipophilic ones through . This explains why abraded or injured
skin, with a damaged epidermis, is more permeable to foreign compounds^.
Opinions on the importance of the cutaneous appendages and ancillary
structures as routes of absorption have been variable, ranging from
256suggestions that they are of minimal quantitative importance to the
view that they are a major pathway for both water soluble and lip id  
112soluble chemicals .
Two major factors that w ill control the passage of a compound through 
the skin are the physical characteristics of the compound and the solvent 
i t  is dissolved in . Physico-chemical characteristics that w ill tend to 
enhance its  absorption are small size, high lip id  solubility  and 
v o la t i l i ty ^ .
Some solvents retard and some enhance absorption through the skin.
Retardant solvents are frequently non-volatile, non-penetrating and
do not react with the stratum corneum, except perhaps to dehydrate
i t  and thereby reduce its  permeability even more to lip id  insoluble
compounds^. Retardation of absorption can also result from the
penetrant forming hydrogen-bonded complexes with the solvent which
lowers its  effective concentration and consequently its  rate of 
128diffusion . Accelerant solvents are usually non-volatile but 
are able to swell the stratum corneum or to remove phospholipid from
1.3.2 Drug Excretion by the Skin
Skin has a known excretory system via the eccrine sweat glands. The
43 145 145permeability of sweat glands to aminopyrine 9 , antipyrine and a
145 253small number of sulphonamide drugs 9 have been investigated.
Passage into the sweat gland was shown to be dependent on lip o p h ilic ity , 
presumably this assists compounds to pass across the sweat gland 
epithelium. Among compounds that possess an ionisable group, those 
that had a pKa close to the pH of sweat, that is about pH 5 .0 , so that 
ionisation was maximal in sweat and minimal in plasma, tended to
145preferentially pass into the sweat gland .
Excretion has also been shown to occur by incorporation into hair and
its  associated lip id . When the flavin 9-phenyl-5,6-benzoisoalloxazime
was injected into albino rats, an orange-yellow pigmentation of the
hair appeared. The pigment in the hair was shown to be either the
original flavin or a derivative spectroscopically indistinguishable 
119from i t  . There have been several reports of polychlorinated
140 143 178biphenyls being present in human hair ancj a] so one report
178of DDT and DDE . I t  has been demonstrated that bromine, probably
as bromophenylcysteine, was covalently bound in the hair of rats
246which had been fed bromobenzene . I t  was suggested that when
bromobenzene was fed to rats on a diet containing insufficient cysteine
for both growth and detoxification, some bromophenylcysteine was
incorporated in the hair in an attempt to make good the lack of 
246cysteine . For compounds which are metabolized slowly but can be
excreted in the hair and its  associated lip id s , i t  has been proposed
that this route of excretion may eventually account for a significant
178proportion of the total dose
C H A P T E R  2 
MATERIALS AND METHODS
2.1 CHEMICALS
7-Ethoxycoumarin was prepared according to the method of Ullrich and 
Weber . 7-Hydroxycoumarin (5 g) was refluxed for 12 hr with a slight 
excess of potassium carbonate and ethyl iodide in acetone (50 ml), over 
a water bath at 61-63°C. After precipitation and recrystallization 7 
three times from aqueous methanol, the product was considered 
homogenous as judged by the melting point (88-89°C) and thin layer 
chromatography (2.5 mm s ilica  gel HF254, Merck) using benzene/ethanol/ 
acetic acid, 96.5:3:0.5 by vol. as solvent.
Obtained from Sigma (Poole) were: NADPH, tetrasodium salt type I;
NADP, sodium salt; NADPH, dipotassium s a lt, grade IV; UDPGA, sodium 
salt; cytochrome C, type I I I ;  sulphatase, type HI; glucose-6-phosphate, 
barium salt; glucose-6-phosphate dehydrogenase, type X II; bovine serum 
albumin, fraction X; 1-naphthol; Coomassie blue G; indoxyl acetate. 
Ketodase was obtained from General Diagnostics (Eastleigh).
Obtained from Koch Light (Colnbrook) were l-naphthyl-£-D-glucuronide;
4-methylumbel liferyl-£-D-glucuroni de; 4-methyl umbel 1i feryl sulphate.
l-Chloro-2,4-dichloronitrobenzene was obtained from Aldrich (Gillingham) 
and was recrystallized from aqueous ethanol before use. Resorufin and 
ethoxyresorufin were obtained from Pierce (Chester). Liebovitz L I5 
medium and foetal calf serum were obtained from Gibco Biocult (Scotland). 
Protein standards used in electrophoresis were obtained from Boehringer 
(Mannheim), protein calibration k it  size 1. Eosin (colour index number 
45380), haematoxylin (Ehrlich's) and Fibro wax (melting point 56°C) 
were obtained from Lambs (London). All other chemicals were of 
laboratory grade or analytical grade where available.
2.2 ANIMALS
Wistar rats (University of Surrey) were used in a ll studies except for 
the hair cycle investigation, where Wistar rats obtained from Olac were 
used. Hairless mice were backcrossed with Balb c mice. Therefore the 
resulting litte rs  were half hairless and half hairy mice. The hairy 
mice were used in several studies, notably the hair cycle investigation. 
For simplicity they are referred to subsequently as Balb c mice. Unless
otherwise stated rats of 45 days and mice of 40-45 days old were used.
C ?^i \yzrc used.
All animals were allowed water and a standard laboratory diet ad libitum. 
The dosage regimens of the various inducers used for mixed function 
oxidase induction are summarized in Table 2.1. Attempts to induce 
glucuronyltransferase activ ity  used the same conditions but for 4 days. 
Corn o il was the carrier used for intraperitoneal administration and 
acetone for topical administration. Topical administration was achieved 
by application by syringe to the back of the animal. After topical 
administration animals were housed separately.
2.3 TISSUE PREPARATION
All homogenization and centrifugation steps were carried out in 20 mM 
Tris-HCl pH 7.4 containing 1.15% w/v KC1, unless otherwise stated.
The conditions of homogenization and centrifugation are dealt with 
in Chapter 3.
Two types of homogenizers were used, a Polytron and a Potter. The 
Polytron (Northern Media Limited, H u ll), a model PT10, acts by shearing 
and, at high speeds, sonicating. The speed was regulated by a rheostat 
with settings of 1 to 10 with a top speed of approximately 20,000 rpm.
Inducer . Route of 
Admi ntstrati on
Length of
Dose
Treatment (days)
3-Methylcholanthrene Intraperitoneal 20 mg/kg 3
5.6-Benzoflavone Intraperitoneal 50 mg/kg 3
7.8-Benzoflavone Intraperitoneal 50 mg/kg 3
5.6-Benzoflavone Topical 1 mg^  3
7.8-Benzoflavone Topical 1 mg^ " 3
TABLE 2.1
Dosage Regimens Employed in Induction Experiments
Carriers used were corn oil for intraperitoneal administration and
acetone for topical application.
t  I * v  O ' f v x l  a c e V o w < .
A glass Potter with a teflon pestle was used. The gap between pestle 
and glass was 0.010 inch.
Separation of the epidermis from the dermis in hairless mouse skin was
255attained by the heating method described by Thompson and Slaga
Skin was placed in 20 mM Tris-HCl pH 7.4 containing 1.15% w/v KC1 at
52°C for 30 sec. The skin was removed and placed in ice-cold buffer,
then removed and the epidermis scraped o ff with one pass of a scalpel.
That a ll the epidermis was removed was checked histologically. This
255process has been shown not to effect AHH activ ity  in mouse skin .
Separation of the epidermis and dermis in rat skin was attained by the 
use of an electrakeratotome (Stortz Instruments, St Louis, USA) at a 
setting of 2 mm. This process cut below the epidermis so that the 
superficial dermis was le f t  attached to the epidermis, and provides 
a cruder separation than that attained by the heat treatment of mouse 
skin.
Rats and Balb c mice were clipped before use. When epidermis-dermis 
separation was to be carried out a depilatory cream, Immac, was also 
used.
For hairless mice a ll the skin from the body was used, while only that 
from the backs of rats and Balb c mice was used. Skin here is defined . 
as a ll the tissue down to and including the pannicuius carnosus and 
this was the starting material for a ll studies.
2.4 ENZYME ASSAYS
2.4.1 Assays in Subcellular Fractions
Acid phosphatase was assayed in a medium that contained 75 mM c itra te -
c itr ic  acid buffer pH 4.9 and up to 0.1 mg tissue protein, in a final 
volume of 3.5 ml. The reaction was started by addition of 4 -n itro - 
phenylphosphate (12 mM final concentration). Incubation was continued 
for 20 min at 37°C. The reaction was stopped with 1.0 M NaOH (2.5 ml) 
and the reaction mixture centrifuged at maximum setting in a bench
centrifuge. The formation of 4-nitrophenol was estimated in the super­
natant from the increase in absorbance at 405 nm. The concentration 
was then calculated using a millimolar extinction coefficient of 
e] ™  18.53 mmol^cm"1.
Succinate dehydrogenase was assayed according to a modified method of
211 217Pennington and Porteous and Clark . The incubation system contained
75 mM sodium succinate (or 75 mM sodium malonate in the blanks),
50 mM potassium phosphate buffer pH 7.4, 2 mM EDTA, approximately
0.3 mg, tissue protein and 0.25 mg of 2(4-indophenyl)-3-(4-nitrophenyl)-
5-phenyltetrazolium chloride (INT) in a final volume of 0.5 ml.
The reaction was started by the addition of the enzyme source. Following
a 15 min incubation at 37°C the reaction was stopped by addition of
10% w/v trichloroacetic acid (1 ml). The formazan formed was extracted
in ethyl acetate (4 ml) and measured spectrophotometrically at 490 nm
1 /~m — 1 — 1
using a millimolar extinction coefficient of E ^ q 20.1 mmol" cm" .
Esterase activ ity  was assayed by a modification of the method described
240by Shephard and Hubscher . The incubation medium contained in a final 
volume of 2.6 ml, 50 mM potassium phosphate buffer pH 6.8, 1 mM EDTA,
0.1% v/v Triton X-100 and up to 0.2 mg tissue protein. After a 4 min 
preincubation at 25°C the reaction was started by addition o f indoxyl- 
acetate to give a final concentration of 2 mM (added in 50 jj.1 of 
methanol) and followed at 386 nm for up to 5 min. A millimolar 
extinction coefficient of  ^ cm  ^ was used to calculate
in it ia l rates.
Lactate dehydrogenase was assayed in a medium containing 66 mM NADH,
6.6 mM sodium pyruvate and 50 mM potassium phosphate buffer pH 7.4 in 
a final volume of 3 ml. The samples were preincubated at 25°C for
4 min and the reaction was started by addition of the enzyme source 
(0.15 mg tissue protein). The reaction was followed at 340 nm in a
. r mo n n  c n o rtrn n h o to m e te r th e rm o s ta te d  a t  2 5 °C . A millimolar
f o ^ N A n ? 0^ 6 was assayed in a mediun containing
1.0 rrM NADP, 6 mM magnesium chloride, up to 0.3 mg tissue nrotpin
and o.l M Tris-HCl buffer pH 8.0 in a final v o W  S T ^ P S ^ l e s  
were preincubated at 25°C for 4 minutes and the reaction starSrhT+h 
addition of glucose-6-phosphate (0.1 nM
thenrostated f? 25^  ^  T "  * UniCa” ^  1800 spectrophotometer,
m mole- cm 1 was iEed 00effi* « rt °f ^.22
mixture contained 100 mM sodium acetate-acetic acid buffer pH 6.5,
5 mM EDTA, 2 mM sodium fluoride and up to 1 mg tissue protein. The 
reaction was started by the addition of glucose-6-phosphate (25 mM 
as the barium salt adjusted to pH 6.5 with 1.0 M HC1). After a
15 min incubation at 37°C the reaction was terminated by plunging 
the tubes in ice-water and adding 10% w/v TCA (1 ml), pi us water 
(0.5 ml). The reaction mixture was centrifuged and the resultant 
supernatant filte re d . The supernatant (1 ml) was used for phosphate 
determination as follows: to the supernatant was added 1 .6% w/v 
ammonium molybdate in 0.5 M H2SQ4 (5 ml) and 20% w/v ferrous sulphate 
in 0.075 M I^SO  ^ (1 ml)> the solutions were mixed and a fter 30 min 
the samples were read at 660 nm. Phosphate standards (0 .2-1 .0  jumol 
KH2P04), and reagent and substrate blanks were carried through the
same procedure.
NADPH cytochrome c reductase activ ity  was determined by the method of 
179Maze! by recording the appearance of reduced cytochrome c at 
550 nm in a s p lit  beam spectrophotometer. The incubation mixture 
contained 50 mM NADPH, 1.0 mM potassium cyanide, 0.67 mM EDTA and 
50 mM potassium phosphate buffer in a final volume of 3 ml. Following 
a 4 min preincubation at 25°C the reaction was started by the addition 
of the enzyme source and followed for 3-4 min. A millimolar extinction
1 /^ m — 1 I
coefficient of E ^ q 18.5 mmol" cm" was used in calculations. The 
amount of tissue protein added was varied and is discussed in Chapter 5.
Glutathione-S-transferase ac tiv ity , using 1-chioro-2,4-dinitrobenzene 
(CDNB) as substrate, was determined by recording the appearance of 
the glutathione conjugate at 340 nm in a s p lit  beam spectrophotometer, 
as described by Habig et a l_ ^ . The incubation mixture contained 
1 mM CDNB, 1 mM reduced glutathione and 0.1 M potassium phosphate
buffer pH 6.5 in a final volume of 2.5 ml. Following preincubation
o ^of 4 min at 25 C, the reaction was started by addition of up to 1.0 mg
1 nm 1
tissue protein. A millimolar extinction coefficient of E ^ q 9.6 mmol" 
cm"^  was used in calculations.
29Glucuronyltransferase was assayed by a modified method of Bock for the 
fluorimetric determination of 1-naphthol glucuronide. The incubation 
mixture contained 5 mM UDPGA, 5 mM magnesium chloride, tissue equivalent 
to 0.6 mg microsomal protein, 0.4 mM 1-naphthol (added in 100 jixl of 
d is tilled  water), 0.1 M Tris-HCl buffer pH 7.6 and,when added, 0.1% 
w/v Brij 35 in a final volume of 0.5 ml. The solutions were incubated 
for 4 min at 37°C after which the reaction was stopped by the addition 
of ice-cold 0.5 M glycine-TCA buffer pH 2.2 (1 ml). UDPGA was without
effect on the fluorescent assay and could be omitted from control and 
standard incubation. A standard of 1-naphthyl glucuronide was added 
to the appropriate tubes. The incubates were then rotary extracted 
for 10 min with chloroform (6 ml) and centrifuged (2000 rpm for 10 min) 
to remove the unreacted naphthol and precipitate the protein. An 
aliquot of the aqueous layer (1 ml) was added to 1.0 M glycine-sodium 
hydroxide buffer pH 10.6 (1 ml) and the fluorescence read at xex. 300 nm 
and xem. 334 nm.
7-Ethoxycoumarin deethylase activ ity  was assayed fluorim etrically by 
measuring the production of 7-hydroxycoumarin. The incubation mixture, 
in a final volume of 1 ml, contained 0.1 mM 7-ethoxycoumarin, 0.5 mM 
NADP, 6 mM glucose-6-phosphate, 1 unit glucose-6-phosphate dehydrogenase, 
0.1 M Tris pH 7.6 and tissue equivalent up to 4.0 mg microsomal protein, 
except for ra t skin after pretreatment with 5,6-benzoflavone when tissue 
equivalent up to 1.0 mg microsomal protein was used. The samples were 
incubated at 37°C for 20 min. The reaction was stopped by addition 
of 0.5 M glycine-TCA pH 2.2 (0.5 ml), then extracted with n-hexane 
(6 ml) for 10 min to extract the unreacted 7-ethoxycoumarin. After 
centrifugation (2000 g for 10 min) the organic phase was discarded and 
the aqueous phase extracted with diethyl ether ( 4 ml) for 10 min, 
and then centrifuged as described above. An aliquot of the diethyl 
ether (2.5 ml) was extracted with 0.2 M glycine-sodium hydroxide buffer 
pH 10.6 (5 ml) for 10 min and then centrifuged as described above.
The fluorescence in the aqueous phase was measured at xex. 370 nm and 
Xem. 450 nm. Standards of 7-hydroxycoumarin were taken through the 
same process.
Ethoxyresorufin deethylase was assayed by a modification of the method
44of Burke and Mayer . The incubation mixture contained 1 j l iM  ethoxyreso-
rufin , up to 3.0 mg microsomal protein, and 0.1 M Tris-HCl pH 7.4 in 
a final volume of 2.5 ml. The reaction was in itia ted  by addition of 
NADPH so as to give a final concentration of 250 j l l M .  The fluorescence 
of the resorufin produced was monitored continuously at xex. 510 nm 
and Xem. 586 nm. The cuvette holder was thermostated at 37°C. A 
standard of 20 nmoles of resorufin was added to each incubation to 
calibrate the assay.
133Cytochrome b5 was measured according to the method of Hrycay and Prough 
in a Varian Carey 219 s p lit beam spectrophotometer. Microsomes were 
diluted to 1-2 mg/ml with 66 mM Tris-HCl buffer pH 7.4 and a base line  
recorded. NADH was added to the sample cuvette to give a final concen­
tration of 0.45 mM and the spectrum recorded. The absorbance difference 
between 409 nm and 424 nm was measured and an extinction coefficient 
of 185 mmole"^  cm’  ^ used to calculate the concentration of cytochrome b^.
209Cytochrome P-450 was measured according to the method of Omura and Sato 
in a Varian Carey 219 s p lit  beam spectrophotometer. Microsomes were 
diluted to 1-2 mg/ml with 66 mM Tris-HCl buffer pH 7.4 and a baseline 
recorded. Both samples were reduced with a few grains of sodium 
dithionite and the sample cuvette bubbled with carbon monoxide and the 
spectrum recorded. Haemoglobin contamination was monitored by bubbling 
the sample cuvette with carbon monoxide and not reducing with sodium 
dithionite and recording the spectrum. An absorption maximum at 420 nm 
indicated the presence of haemoglobin.
Mixed function amine oxidase was measured by a modification of the
291method of Ziegler and P e ttit . The incubation mixture contained in 
a final volume of 3 ml, 0.1 M Tricine pH 8.4, 0.5 mM NADP, 6 mM glucose-
6-phosphate, and 3 units glucose-6-phosphate dehydrogenase and was
incubated for 4-6 min at 37°C before addition of the enzyme source.
The reaction was started by the addition of dimethyl aniline to give a 
final concentration of 2 mM. Aliquots (0.9 ml) were removed at 0 and 
6 min and added to 3.0 M TCA (0.12 ml) and centrifuged at top speed in 
a bench centrifuge fo r*5 min. An aliquot (0.9 ml) was removed and 
added to 1.0 M sodium bicarbonate (0.2 ml) and 6.0 M potassium 
hydroxide (0.06 ml) and then extracted three times with diethyl ether, 
discarding the organic phase. The aqueous samples were incubated for
2-3 min at 60°C to remove the last traces of diethyl ether. An aliquot 
(0.9 ml) was removed and added to 1.0 M glycine-TCA pH 2.5 (0.2 ml),
3.0 TCA (0.08 ml) and 0.15 M sodium n itr ite  (0.1 ml). The samples 
were incubated for 6 min at 60°C. After cooling to room temperature 
the samples were read at 420 nm. An extinction coefficient of E^o*1 
7.3 mmol^ cnf  ^ was used in the calculation of p-nitrosodimethylaniline.
The method of Goodwin and Choi^ vas used for a ll protein estimations except
in the preparation of microsomal samples for electrophoresis where the
167method of Lowry et al was used.
(a) Goodwin and Choi Method: Samples were diluted to 100-200 jugm protein/ 
ml with 0.1 M sodium tetraborate. To a 0.5 ml aliquot of the protein 
sample was added a combined reagent (3 ml). The combined reagent was 
composed of equal volumes of 0.05% w/v 2,4,6-trinitrobenzenesulphonic 
acid, 0.05 M sodium sulphite and 0.1 M sodium tetraborate, and should 
be made up freshly. Samples were stood at room temperature for 10 min 
and then incubated at 70°C for 15 min. After cooling to room temperature 
they were read at 420 nm. Standards of 50-250 jj.gm/ml bovine serum 
albumin were taken through the same procedure.
(b) Lowry Method: Samples were diluted to 100-200 jagm protein/ml with 
0.05 N sodium hydroxide. Aliquots (0.5 ml) were then diluted with 
fresh Lowry reagent (5 ml). The Lowry reagent was composed of 2% w/v 
^ C O g /l% w/v Cu SO^ /2% NaK tartrate (100:1:1 by vo l). The samples 
were allowed to stand for 10 min at room temperature. After this time 
50% v/v Folin-Ciocafteau reagent (0.5 ml) was added to each sample and 
mixed well. After 30 min the absorbance at 720 nm was recorded.
Standards of 50-250 jugm bovine serum albumin/ml were taken through the 
same procedure.
2.4.2 Assays in Skin Strips
7-Ethoxycoumarin metabolism was assayed using a substrate concentration 
of 70 jiM in an incubation volume of 2 ml. After the appropriate 
incubation period at 37°C the strips were removed and frozen. Two 
aliquots (0.75 ml) were taken from the remaining medium. These samples 
were extracted for 10 min with hexane (6 ml). After centrifugation 
(2000 g for 10 min) the organic phase was discarded. The aqueous phase 
was then extracted for 10 min with diethyl ether (4 ml). After 
centrifuyation an aliquot of the diethyl ether (2.5 ml) was extracted 
with 0.2 M glycine-sodium hydroxide buffer pH 10.6 (5 ml) for 10 min. 
After centrifugation the fluorescence of 7-hydroxycoumarin in the 
aqueous phase was read at xex. 370 nm and Xem. 450. To the aqueous 
phase from the idiethyl ether extraction^,w^added Ketodase (0.5 ml) and 
incubation was then carried out overnight^ Ketodase is a 3-glucuronidase 
preparation free from sulphatase ac tiv ity . The samples after incubation 
were extracted as before (except that the hexane extraction was omitted) 
and the 7-hydroxycoumarin assayed. To the aqueous phase from the 
diethyl ether extraction was added 5 mg sulphatase in 0.2 M acetate 
buffer pH 4.0 (0.5 ml) and incubation was then carried out o v e rn ig h t^ ^
The samples were treated as for the Ketodase incubation. Standards 
were'.taken through each incubation and extraction procedure. The 
strips that were frozen were freeze dried and the dry weight recorded.
7-Hydroxycoumarin metabolism was assayed using a substrate concentration 
of 70 mM in an incubation volume of 2 ml. After the appropriate incubation 
period at 37°C the strips were removed and processed as described 
previously. Two aliquots (0.75 ml) were taken from the remaining medium. 
These samples were extracted with diethyl ether for 10 min and after  
centrifugation (2000 g for 10 min) the organic phase was discarded.
This was repeated twice more. This process removed unreacted 7-hydroxy- 
coumarin. The samples then underwent subsequent Ketodase and sulphatase 
incubations as described previously for the assay of 7-ethoxycoumarin 
metabolites..
2-Hydroxybiphenyl metabolism was assayed using a substrate concentration
of 70 j-iM in an incubation volume of 2 ml. After the appropriate incubation 
period at 37°C the strips were removed and processed as described 
previously. Two aliquots (0.75 ml) of the remaining medium were taken 
and incubated with Ketodase and sulphatase as described previously.
After overnight incubation the samples were extracted with iso-octahe 
(7 ml) for 10 min then centrifuged (2000 g for 10 min). The organic 
layer (6.5 ml) was filte re d  through a 0.45 jum teflon f i l t e r  and then 
evaporated to dryness in a 10 ml pear-shaped flask at 40°C on a rotary 
evaporator. The residue was redissolved in 50 x^l of isoctane/acetonitrile/
3-methylbutan-l-ol (25:1:1 by vol). A 30 jllI portion of this was injected 
on to a column (25 cm) of bonded-phase silica-NH^ attached to a high- 
pressure liquid-chromatography instrument. The sample was eluted with 
the solvent used to redissolve the sample after evaporation (flow rate
1.5 ml/min) at room temperature and was analysed at 254 nm in a flow-
through spectrophotometer. Standards were taken throught:.the same 
incubation and extraction procedures.
The investigation of the metabolism of 4-hydroxybiphenyl was the same 
as for 2-hydroxybiphenyl.
Oxygen uptake by the strips was detected using a Gilson respirometer.
The same incubation conditions as those used for metabolism studies 
were employed.
2.5 ELECTROPHORESIS
Gel electrophoresis of microsomal proteins was carried out by the method
161 aof Laemmli on a vertical slab gel apparatus. The gel was contained 
in a glass and perspex cuvette, with internal dimensions of 120 mm x 100 mm 
x 1.5 mm. Electrophoresis was carried out at room temperature. The glass 
plates of the gel cuvette were washed in detergent, rinsed with tap water, 
d is tille d  water, methanol, acetone and allowed to dry. The cuvette 
was assembled and sealed with 1.5% w/v molten agar and then clamped in 
a vertical position. The lower (running gel) was prepared by mixing 
150 mM Tris-HCl (pH 8.8) containing 0.4% w/v sodium dodecyl sulphate 
(10 ml), 30% w/v acrylamide containing 0.8% w/v N,N'-methylene bis- 
acrylamide (13.3 ml), water (16.6 ml) and polymerization was in itia ted  
by addition of N,N'-tetramethylethylenediamine (TEMED) (20 jul) and 
freshly prepared 10% w/v ammonium persulphate solution (240 jul). The 
solution was poured into the glass cuvette to a height of 80 mm. A 
layer of d is tille d  water was introduced above the gel mixture to ensure 
a f la t  interface between the separating gel and stacking gel a fter  
polymerization. When polymerization of the running gel was complete 
the water layer was removed and the upper (stacking) gel, consisting
of a mixture of 500 mM Tris-HCl (pH 6.8) containing 0.4% w/v SDS 
(2.5 m l)9 30% w/v acry!amide, containing 0.8% w/v N,N'-methylenebis- 
acrylamide (1.0 ml), water (6.5 ml), 10% w/v ammonium persulphate 
solution (60 p/l) and TEMED (20 jul) was added to the cuvette above 
the running gel. A perspex comb was introduced into the stacking gel 
before polymerization to form the sample walls. The comb; was removed 
when polymerization of the gel was complete and a small amount of 25 mM 
Tris-HCl (pH 8.3) containing 192 mM.glycine and 0.1% w/v SDS was 
introduced into the sample wells to keep them separate. The lower 
spacer was removed from the cuvette, and the cuvette was then placed 
in the electrophoresis tank, 25 mM Tris-HCl (pH 8.3) containing 192 mM 
glycine and 0.1% w/v SDS was added to the upper and lower reservoirs, 
and a ir  bubbles trapped underneath the gel were removed using a syringe.
Microsomal suspensions were diluted with 62.5 mM Tris-HCl (pH 6.8)
k
containing 23% w/v SDS, 15% v/v glycerol, 5% v/v 2-mercap)pethanol and 
0.001% w/v bromophenol blue to a final concentration of 1 mg protein/ml 
for liver and 2 mg protein/ml for skin. Samples were placed in a boiling 
water bath for 3 min. The samples were cooled and applied to the 
stacking gel. The amount of protein for electrophoresis of microsomal 
proteins was 10 jugm for liver and 20 jagm for skin. A constant current 
of 20 mA was used until the bromophenol blue entered the separating 
gel, and then this was increased to a constant current of 40 mA until 
the bromophenol blue was within 5 mm of the end of the gel. The 
cuvette was removed from the tank when electrophoresis was complete.
The glass plates were separated and the stacking gel removed.
The gels were stained overnight in isopropanol/acetic acid/water 
(25:10:65 by vol) containing 0.05% w/v Coomassie blue G. The gels were 
then destained in isopropanol/acetic acid/water (10:10:80 by vol) until 
the background was clear.
2.6 HISTOLOGY
Skin was excised from the mid-dorsal region of the animals and placed 
onto card to prevent i t  curling. I t  was then placed in 50 mM phosphate 
buffer (pH 7.0) containing 10% v/v formaldehyde and 0.9% w/v NaCl and 
le f t  for at least four days. The samples were then dehydrated in a 
Histokinette (British American Optical Co Ltd). This processed the 
samples for an hour each in 70%, 85%, 95% ethanol and for three times 
for one hour periods in 100% ethanol, twice in toluene and f in a lly  a 
wax bath. The samples were then set in wax, carefully orientating the 
skin samples so that when cut they would show the complete hair 
fo llic le s . When the wax had set the blocks were cut by a rotary micro­
tome (British American Optical Co Ltd) set at 10 nm. The sections 
were floated on tepid water then transferred to microscope slides and 
dried. The sections were stained with haematoxylin and eosin as follows 
dewaxed in xylene (2-3 min); immersed in 100% alcohol (1 min), 70% 
alcohol (1 min), 50% alchohol (1 min), d is tille d  water (rinse), 
haematoxylin (10 min), blue in tap water (10 min), differentiated in 
1% acid alcohol (5 sec), blue in tap water (10 min), 1% eosin (4 min), 
85% alcohol (30 sec), 100% alcohol (30 sec), 100% alcohol (30 sec), 
and fin a lly  xylene until mounted in DPX.
C H A P T E R  3 
PREPARATION OF SUBCELLULAR FRACTIONS AND STRIPS FROM SKIN
3.1 INTRODUCTION
Many different types of approach have been used to investigate drug 
metabolism, ranging from purified enzymes to in vivo studies.
Whichever preparation is chosen i t  can only be used effective ly , and 
the results obtained interpreted correctly, i f  t,he limitations and 
drawbacks of that particular preparation are known. This is of 
especial importance when working with a tissue,such as skin, where 
the methodology is not well developed. Two preparations were 
employed in the present study, subcellular fractions and skin strips.
In general, subcellular fractions from extrahepatic tissues are prepared 
using the same procedures developed for liv e r. However, these tissues 
w ill not necessarily respond in the same way as the liver to a particular 
set of homogenization and centrifugation conditions. Very few investigat­
ions of the best methods for preparing subcellular fractions from 
extrahepatic tissues have been carried out.
Three c rite ria  should be considered in the preparative isolation of 
subcellular fractions. F irs tly , the morphological, chemical and 
enzymic properties of the organelle should not be altered by the 
procedure used. Secondly, recovery of the organelle should be high 
to guard against obtaining a non-representative subfraction. Finally  
the isolated fraction should be free from contamination by other 
organelles. I t  is impossible in practice to achieve a ll these goals, 
so a ll procedures represent a compromise. The investigator must often 
choose between higher recovery and lower purity, or lower recovery and 
higher purity. The conditions selected for homogenization usually 
represent a major compromise between good yield and high purity of 
fractions. In many previous investigations very vigorous methods have
been employed to homogenize skin. In the present study the efficiency  
and resulting unwanted damage to skin organelles was investigated.
The subcellular fraction of major interest to this investigation was 
the microsomal fraction. Therefore, a simple subcellular fractionation 
scheme was employed and studies on the distribution of other fractions 
were mainly carried out to ascertain the extent of contamination of the 
microsomal fraction.
Skin strips have previously been used to investigate the metabolism of
248 239such compounds as 2-ami nophenol and various androgens . In the
present study a skin strip  preparation was developed for the quantitative
and qualitative measurement of drug metabolizing a c tiv ities . The use of
strips is an important alternative to subcellular fractions because strips
avoid many of the possible artefacts formed by homogenization.
3.2 RESULTS
3.2.1 Subcellular Fractionation
3.2.1.1 Efficiency of homogenization
Unless stated to the contrary, 20 mM Tris-HCl buffer pH 7.4 containing 
1.15% KC1 was used for homogenization and centrifugation procedures and 
pellets were resuspended in 66 mM Tris-HCl pH 7.4. In it ia l ly ,  
preliminary disruption was accomplished by scissor chopping. Although 
this was found to be adequate for mouse skin, i f  chopped fine ly  enough, 
i t  caused d ifficu lties  in the further processing of rat skin in that 
the relatively  large pieces of rat skin clogged the Polytron, reducing 
the efficiency and reproducibility of homogenization. I t  also made use
of the Potter homogenizer dangerous due to the possible breakage of 
the glass. To overcome this in subsequent experiments, the skin was 
frozen rapidly in liquid nitrogen and powdered in a mortar and pestle. 
This made the starting material from rat and mouse skin comparable and 
increased the a b ility  of homogenizers to process them. Further studies 
on the efficiency of homogenization were carried out using the skin 
from the backs of 45 day old rats. This skin was chosen as i t  was 
the thickest to be encountered during the investigation.
To monitor breakage of ce lls , the release of two soluble enzymes,
lactate dehydrogenase and glucose-6-phosphate dehydrogenase, into the
v*eas«red
homogenizing medium was assayed. Both enzymes have previously been
18 181reported to be present in skin * . The results obtained are
shown in Tables 3.1, 3.2 and 3.3. When using the Polytron the highest 
specific activ ities  were achieved at the lowest speed and the shortest 
time investigated. When these values were compared to those obtained., 
using the harshest homogenization conditions, the specific ac tiv ity  
of lactate dehydrogenase and glucose-6-phosphate dehydrogenase, as 
expressed per gram wet weight of tissue, decreased 10% and 36% 
respectively. The decreases were greater when the activ ities  were 
expressed per mg protein, 18% and 45% for lactate dehydrogenase and 
glucose-6-phosphate dehydrogenase respectively. When homogenized by 
the Potter the specific ac tiv ities , as expressed per mg protein, were
cm lwcv~«os-e o f
higher than those obtained by using the Polytron, 133%-ttp for glucose-6-
aw \wi\rea6'£ of
phosphate dehydrogenase and 20%=op for lactate dehydrogenase. However,
the specific activ ities  as expressed per gram wet weight of tissue 
a decrease of
were decreased, 35fatownrfor glucose-6-phosphate dehydrogenase and 
cx decrease o f
30%zdowft for lactate dehydrogenase.
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3.2.1.2 Effects of homogenization
The effect of homogenization on the distribution of succinate dehydrogenase,
173a marker for the inner mitochondrial membrane , was investigated.
This was achieved by measuring the percentage of activ ity  peTTeted -down 
Juri*a
afte r centrifugation of the homogenate at various speeds. The
4
centrifugation conditions used were 10,000 g for 30 min (30 x 10 g min),
24,000 g for 30 min (72 x 10  ^ g min) and 105,000 g for one hour (632
4
x 10 g min). The la tte r  denotes the conditions used conventionally 
for pelleting microsomes. After Polytron homogenization of ra t skin, 
less succinate dehydrogenase activ ity  was recovered in the pe lle t at 
the lower spin speeds, as shown in Figure 3.1. The amount recovered 
in the pelle t also depended on the length of time of homogenization, 
the longer the time the smaller the recovery. After Potter homogenization 
the recovery of succinate dehydrogenase in the pelle t was independent 
of the centrifugation conditions used.
A similar study with hairless mouse skin showed that the recovery of 
succinate dehydrogenase in the pelle t was independent of both homo­
genization technique and centrifugation conditions (*70%).
Polytron homogenization also reduced the activation by B rij 35 of 
1-naphthol glucuronidation in rat skin homogenates. As shown in 
Table 3.4, after Polytron treatment the activ ity  in rat skin 
homogenates was almost fu lly  activated. In contrast when the Potter 
was used, the activ ity  was almost doubled by the addition of the 
detergent. The method of homogenization had no effect on the activation  
of glucuronidation in either of the mouse strains investigated.
FIGURE 3.1
Recovery of succinate dehydrogenase in the pellets obtained from rat 
skin homogenates subjected to different centrifugation conditions.
Results are expressed as mean and standard deviation of three experiments
•  Polytron, setting 2.5 for 20 sec 
■ Polytron, setting 2.5 for 10 sec 
a Potter, 5 passes
Species Potter Homogenization Polytron Homogenization
Rat 187 ± 15 114 ± 10
Mouse 132 ± 10 137 ± 16
(Balb C)
Mouse 164 ± 6 160 ± 4
(Hairless)
TABLE 3.4
Activation of UDP-Glucuronyltransferase by B rij 35 (0.1% v/v) in Skin 
Homogenates after Different Types of Homogenization 
Results are expressed as percentage of control and are the mean and 
standard deviation of three experiments.
Potter homogenization, 5 passes.
Polytron homogenization, 10 sec at speed 2.5.
The effect of homogenization on the distribution of glucuronyltransferase
with 1-naphthol as substrate, between the pellet and supernatant after
the homogenate had been centrifuged at different speeds was investigated.
4
The centrifugation conditions used were 8,000 g for 20 min (16 x 10 g
4
min) and 10,000 g for 30 min (30 x 10 g min). As shown in Figure 3.2b, 
use of the Potter for homogenizing hairless mouse skin resulted in the 
highest percentage of activ ity  residing in the supernatant. Increasing 
the spin speed decreased the activ ity  in the supernatant. Use of the
4
Polytron and centrifugation for 30 x 10 g min resulted in only 27% of 
the activ ity  being present in the supernatant. When rat skin was used 
(Figure 3.2a), unlike hairless mouse skin, Polytron homogenization 
resulted in the highest recovery of ac tiv ity  in the supernatant. 
Increasing the spin speed again decreased recovery in the supernatant,
especially when the Potter was used, when after centrifugation for
4 ■30 x 10 g min only 30% of the activ ity  remained soluble. Use of
250 mM sucrose instead of 1.15% KC1 in the homogenization buffer had 
no effect on the distribution of activ ity  in either rat or mouse skin.
In these studies on glucuronyltransferase distribution no detergent was 
added to the incubations and the total recovery in the pe lle t and super­
natant was always in excess of 90%. Washing of the premicrosomal 
pelle t, from either species, a fter Potter homogenization resulted in 
a similar amount of activ ity  being released into the supernatant (about 
10% of the total a c tiv ity ).
3 .2.1.3 Subcellular distribution studies
Potter homogenization (five passes) and a f ir s t  centrifuge spin of
8,000 g for 20 min, followed by a spin of 105,000 g for one hour, to 
harvest the microsomes, was used for a ll samples in this study. The 
distribution of enzyme activ ities  in the fractions from hairless mouse
(a)
(b)
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FIGURE 3.2
Recovery of glucuronyl transferase activ ity  in the supernatant obtained from 
skin homogenates subjected to different centrifugation conditions. Results 
are expressed as the mean and standard deviation of three .experiments 
•  Polytron, setting 2.5 for 10 sec (a) Rat
■ Potter, 5 passes (b) Hairless Mouse
and rat skin is shown in Tables 3.5 and 3.6. Succinate dehydrogenase 
activ ity  was recovered mainly in the premicrosomal pelle t in both rat 
and hairless mouse preparations, with the microsomes from both species 
being contaminated to the same extent of 13%. Recovery was lower in 
the rat (82%) than the mouse (91%). This may have been due to any 
activ ity  present in the rat high speed supernatant being too low to 
detect. The majority of acid phosphatase ac tiv ity , in both species, 
was present in the high speed supernatant. The microsomes contained 
a considerable amount of activ ity  and had the highest specific activ ities  
of the fractions. To determine i f  the freezing in liquid nitrogen 
affected the distribution of succinate dehydrogenase or acid phosphatase, 
hairless mouse skin was scissor chopped and homogenized using the Potter. 
The distribution of enzymes observed after this treatment were the 
same as those observed a fter treatment with liquid nitrogen.
The activ ity  of indoxyl acetate esterase was s^r^pd throughout the 
fractions, with the highest percentage of ac tiv ity  being in the high 
speed supernatant. This is similar to the distribution of acid 
phosphatase. In contrast to acid phosphatase, however, the microsomes 
contained a higher percentage of esterase activ ity  than the premicrosomal 
pelle t. The microsomes also had by far the highest specific a c tiv ity .
Both activated and native preparations of glucuronyltransferase were 
assayed. Both gave rise to very similar distributions. In the hairless 
mouse the majority of the activ ity  was present in the microsomes, 61%, 
but in the ra t the activ ity  was evenly spread between the microsomes 
and the premicrosomal fraction. Glucose-6-phosphatase ac tiv ity  was not 
detectable in either species. NADPH cytochrome c reductase could not 
be used as a marker enzyme because low levels made measurement in 
homogenates impossible.
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Nearly a ll the glutathione-S-transferase activ ity  was located in the 
high speed supernatant from hairless mouse skin. Data from the rat 
was less rtp'rocWe but showed a similar distribution to the hairless 
mouse in that only the high speed supernatant showed significant 
activ ity . Distribution of protein was generally similar in the two 
species, except that the microsomes from the rat had almost double! 
the percentage of protein in this fraction compared to hairless mice.
3.2.1.4 S tab ility  of cytochrome P-450
Various compounds (see Table 3.7) were included in the preparation of 
microsomes from hairless mouse skin in an attempt to increase ethoxy- 
resorufin deethylase ac tiv ity . All the compounds, except for glycerol 
which was added to the resuspension buffer, were added to the 
homogenization buffer. None of these compounds produced an increase 
in enzyme activ ity .
Skin, from either hairless mouse or ra t, was mixed with live r homogenates 
or microsomes to see i f  breakdown of hepatic cytochrome P-450 would occur.
The livers from control, 3-methylcholanthrene and phenobarbitone pre­
treated rats were used in order to assess the possible effects of skin 
homogenates on a range of concentrations and types of hepatic cytochrome 
P-450. No decrease was seen in any hepatic cytochrome P-450 or in cyto­
chrome b^  levels.
3.2.2 Skin Strips Preparation
Skin from the backs of rats or hairless mice was cut into strips 1 mm wide and 
incubated in Liebovitz L15 medium. The s tab ility  of conjugates to prolonged- 
incubation was also investigated because preliminary experiments indicated
Compound Concentration Reason for Use
EDTA
Dithiothrfcitol
Ficoll
DMSO
Foetal Calf Serum 
Glycerol
5 x 1 0 " 3 M 
6x10 " 4 M
1.5% w /v  
1.5% w /v  
10% w /v
10% w/v
Inhibitor of lip id  peroxidation (re f 136) 
Anti oxidant
Protects cytochrome oxidase in 
skin homogenates (re f 94)
Protease inhibitor (re f 65)
Protects cytochrome P-450 breakdown, 
mechanism unknown (re f 278)
TABLE 3.7
Compounds added to Hairless Mouse Skin Preparations in an attempt to 
Increase Ethoxyresorufin Deethylase
All compounds added to homogenization buffer except for glycerol 
which was added to the resuspension buffer.
that hydrolysis of conjugates^pccurred in the absence of added acid hydro- 
1 ases. 4-Methyl umbel 1i feryl gl.ucuron.ide (10 nmol.es/ml) was i ncubated over­
night in fresh medium and medium that had.been preincubated with either rat 
or-hairless mouse.skin strips for one hour and then the strips removed. The 
results are.shown :in Table 3 ’8 .' WlTen ketodase- was added, and the pH of the 
medium adjusted to 5.0, a ll the glucuronide was hydrolysed in both
(i*n)
fresh and preincubated medium. Saccharic acid-1,4-lactone^inhibited 
this. When no enzyme was added and the medium adjusted to pH 5.0 a ll 
the conjugate in the preincubated medium was hydrolysed, whereas no 
breakdown occurred in the fresh medium. The breakdown in thevpre-
C-fl)
incubated medium was inhibited by saccharic acid-1,4-lactoneA. Overnight 
0( f k }  A
incubationXat pH 7.4, in the absence of added hydrolases, led to a
partial breakdown of,the glucuronide in the preincubated medium. The
factor, therefore, that is apparently being released from the skin
strips has the characteristics of acid g-glucuronidase. In a similar
study using 4-methyl umbel!iferyl sulphate, no detectable breakdown of the
conjugate by factors of an endogenous origin was observed in the absence
of added hydrolases.
I t  was considered possible that this leakage of ^-glucuronidase into 
the medium could interfere with measurement of glucuronides formed by 
the strips, by hydrolysing them during the incubation. To investigate 
thisy4-methyl umbel!iferyl glucuronide, at concentrations of 0.5 and 
10 nmoles per ml, was incubated for one hour in medium that had previously 
been incubated with either rat or hairless mouse strips for one hour, 
and then removed. When the medium was kept at pH 7.4 no breakdown 
was detectable after this time, however, i f  the medium was adjusted 
to pH 5.0 approximately 20% of the glucuronide was hydrolysed in one 
hour. Possible breakdown was also monitored by the incubation of
Additions
pH of 
Incubation
Preincubated
Medium
Fresh
Medium
Ketodase 5.0
Ketodase +
Saccharic acid-1,4- 5.0
lactone
Acetate Buffer 5.0
Acetate Buffer +
Saccharic acid-1,4- 5.0
lactone
No addition 7.4
TABLE 3.8
Release of B-Glucuronidase from Skin Strips
4-Methyl umbel!iferyl glucuronide (10 nmol/ml) was incubated overnight 
in Liebovitz LI5 medium that was either fresh or had been incubated 
for 1 hour with either rat or hairless mouse skin strips.
+ Total hydrolysis of glucuronide 
± Partial hydrolysis of glucuronide 
-  No detectable hydrolysis of glucuronide
7-ethoxycoumarin with rat or hairless mouse skin strips for one hour, 
after which the strips were removed and an aliquot was assayed for 
7-hydroxycoumarin, while the rest was incubated for a further hour 
before being assayed for the free metabolite. No additional 7-hydroxy- 
coumarin was found after two hours incubation than after one hour.
This experiment was carried out with control animals and also hairless 
mice topically induced by 5,6-benzoflavone and rats induced by in tra - 
peritoneal administration of 3-methylcholanthrene. The results were 
similar in each case. Therefore, leakage of B-glucuronidase into the 
medium was not deemed a problem as long as the incubation was for one 
hour or less and was maintained at pH 7.4.
Incubations with 7-ethoxycoumarin or 7-hydroxycoumarin were performed 
in 10 ml conical flasks containing 2 ml of Leibovitz LI5 medium. After 
incubation the strips were removed and freeze dried and the dry weight 
recorded. This weight was used in the calculation of specific a c tiv itie s . 
Incubation under oxygen did not enhance a c tiv itie s , however, use of 
other vessels which resulted in a decreased surface area decreased 
activ ity . Figure 3.3a and b shows the relationship between glucuron­
idation of 7-ethoxycoumarin and the amount of ra t or hairless mouse 
strips present. When hairless mouse strips were used a linear 
response was observed up to about 50 mg dry weight of skin per incubate 
while the ra t strips were linear with activ ity  up to approximately 
35 mg dry weight per incubate. Assuming that the dry weight is about 
one third the wet weight, then providing the wet weight of the strips is 
under 100 mg metabolism should be within the linear phase. Oxygen 
uptake of the strips was used as an indication of v ia b ility . The 
results are shown in Figure 3.4. Uptake was approximately linear over 
one hour incubation with both rat and hairless mouse skin strips.
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FIGURE 3.3
Relationship between rate of glucuronidation of 7-hydroxycoumarin and 
dry weight of skin strips per 2 ml incubation, (a) Hairless mouse,
(b) rat. Data represents results from two experiments.
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FIGURE 3.4
Uptake of oxygen by skin strips. 
Conditions as in Materials and Methods.
■ Hairless mouse 
• R a t
3.3 DISCUSSION
3.3.1 Subcellular Preparation
3.3.1.1 Homogenization
Study of the release of the two soluble enzymes (lactate dehydrogenase
and glucose-6-phosphate dehydrogenase) indicated that homogenization of
skin does not need the extremely harsh conditions that have been used in
some previous investigations. The decrease in activ ity  with increasing
time and speed of Polytron homogenization could be due to release
of an increasing proportion of non-active protein or damage to the
enzymes. That the decrease in specific activ ity  was greater when
expressed per mg protein than per gm wet weight suggests that the.;
decrease was due to a mixture of both possib ilities, enzyme damage,
with glucose-6-phosphate dehydrogenase being the most susceptible,
and dilution with non-active protein, probably structural proteins.
Damage by too vigorous homogenization has been overlooked in a ll except
one of the previous studies on drug metabolism in the skin. In this
one previous report the effect of homogenization on mouse epidermal 
2AHH was studied . The conditions used were s t i l l  harsher than those 
employed in this study. Epidermal samples were homogenized in a Potter 
for 25 passes. One portion was then homogenized for 3 min with a 
Polytron at setting '3 '.  The Polytron treatment resulted in a loss 
of about 60% of the ac tiv ity . In the present study Potter homogenization 
resulted in only about 60% of the ac tiv ity , as expressed per gm weight, 
than that obtained by the Polytron, but the specific ac tiv ity  when 
expressed per mg protein was slightly increased. Therefore damage 
may be avoided using the Potter as the method of homogenization.
However, since the yield was decreased i t  raises the problem of non- 
representatiive homogenization.
Our data from studies on succinate dehydrogenase distribution and
glucuronyltransferase activation indicate that damage occurred to
organelles and membranes on Polytron homogenization of ra t preparations,
but not in mouse preparations. Succinate dehydrogenase is a marker for
the inner mitochondrial membrane, which also contains cytochrome 
173oxidase . Therefore, contamination of microsomes with succinate
dehydrogenase w ill mean contamination with cytochrome oxidase. This is
to be avoided i f  possible as i t  has been demonstrated that cytochrome
oxidase, which has an absorption minimum at 444 nm interferes with
215spectral measurement of cytochrome P-450
The Balb c strain of mice was. included in the study of the activation
of glucuronyltransferase to determine whether the difference between
rat and hairless mouse was due to species differences or to the degree
of hairyness. The results showed that i t  did appear to be dependent
on species and not hairyness. The activation in the rat a fte r Polytron
homogenization in the absence of detergent could be due either to the
release or activation of some factor in the homogenate or mechanical
damage. The la tte r has been shown to lead to activation in liv e r
preparations. I t  has been suggested that processes such as sonication,
blending and grinding with glass activate by causing mechanical
23 24rupture of glucuronyltransferase containing vesicles 5 . Mechanical
damage alone, however, does not seem to be the cause as the mouse 
preparations remained unactivated after identical Polytron homogenization. 
I t  may be due to an endogenous factor in the rat preparations being 
released, which destabilizes the membrane making i t  more susceptible to 
mechanical damage.
The distribution of glucuronyltransferase, an enzyme found predominantly
in the microsomes in liver^ , indicated that i f  the homogenization
and centrifugation conditions were not chosen carefully, up to 70%
of the microsomes could be lost by being pelleted in the premicrosomal
pelle t. In the hairless mouse the loss of activ ity  at the slower spin
speed was increased by Polytron homogenization. This may be due to
entrapment of endoplasmic reticulum by fragments of plasma membrane
and other organelles. The converse situation occurred in ra t skin, that
is Potter homogenization resulted in the lowest yield in the supernatant
This may have been due to ineffic ien t homogenization resulting in a
relative ly  large amount of unbroken or partia lly  broken cells . The
large proportion of microsomes pelleting at re latively  low g values was
not due to aggregation of the microsomes, as shown by the lack of
effect of changing to a sucrose homogenization buffer. Sucrose buffers
109 144have been shown to reduce aggregation in live r and lung microsomes
Sedimentation of microsomes at low g values is not unknown and has been
62reported for human foetal live r microsomes .
Because of the damage to ra t preparations and the smaller microsomal
recoveries in mouse preparations due to Polytron homogenization, Potter
homogenization was chosen for further work. Also a f ir s t  centrifugation
step of 800 g for 20 min was used to increase the microsomal recovery.
The microsomes were harvested from the supernatant by centrifuging at
105,000 g for one hour. Washing the premicrosomal pellet was not
included in deference to the need for speed in preparation of the
fractions. For spectral studies the microsomal pelle t was washed by
resuspending the pellet and repeating the spin at 105,000 g for one
-  h°U£—-----  ■--------------------------
Polytron homogenization was used instead nf Pnt-fQv.
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3 . 3 . 1 . 2  S u b c e l l u l a r  d i s t r i b u t i o n  s t u d i e s
Acid phosphatase was distributed throughout the skin fractions, which
is quite different to the situation in liv e r. There is histochemical
54 125evidence for the presence of lysosome like particles in ra t 9 ,
58 83 208mouse 9 and human skin . These particles meet the morphological
269crite ria  of Weissman for lysosomes, namely an in tracellu lar organelle 
bounded by a single membrane, giving a positive reaction for acid 
phosphatase. Acid phosphatase activ ity  has also been demonstrated in
pqc ?Qq
melanosomes 9 . However, previous attempts to identify lysosomes
in skin by subcellular studies in skin have not met with success. As
in the present study, the majority of activ ity  of lysosomal ac tiv ities
have been found in the supernatant a fter using centrifugation conditions
with which the lysosomes should have been pelleted down. Table 3.9
lis ts  the lysosomal activ ities  for which this spread of ac tiv ity
between the fractions has been demonstrated in skin. The recurrent
observation of acid phosphatase activ ity  being distributed in both
lysosomal and supernatant fractions has led to the suggestion by some
38 184investigators that there may be two distinct cutaneous ac tiv ities  9 .
However, other studies indicate that the dual localisation of acid 
phosphatase is most like ly  secondary to disruption of lysosomes, since 
both lysosomal and cytoplasmic acid phosphatase have the same electro­
phoretic mobility in agarose gel and both enzymes behave sim ilarly to
2Dfitartrate and alloxan . Whatever the source, the presence of ly tic  
enzymes in cell fractions must be expected and taken into consideration. 
The percentage of acid phosphatase activ ity  recovered in the skin 
microsomal fraction in this study, 14% for the hairless mouse and 20% for
the ra t, is similar to the percentage reported to be found in ra t 
liv e r microsomes, 17%7.
Enzyme Reference
Acid Phosphatase 81, 201, 237, 251
Cathepsin 81, 237
3-Glucuronidase 81, 244
Aryl Sulphatase 81
a-Glucosidase 244
N-Acetyl-3-Glucosaminidase 244
a-Galactosidase 244
TABLE 3.9
Enzyme Activities Normally Associated with Lysosomes which have, in 
Skin, been Demonstrated to be Present Mainly in the Microsomal and 
High Speed Supernatant Fractions in Cell Free Preparations
173Succinate dehydrogenase, a mitochondrial marker , showed a similar 
distribution in both rat and hairless mouse skin preparations. The 
majority of ac tiv ity  was found, as expected, in the premicrosomal 
fraction. The importance of having as l i t t l e  contamination of the 
microsomes by mitochondria has already been discussed. The contamination
of the microsomes by the inner-mitochondrial membrane, 13%, compares
7 262with the reported values of 4% for liv e r and 2% for small intestine
The potential for interference in skin is also greater due to the very
low levels of cytochrome P-450 present. The presence of succinate
dehydrogenase activ ity  in the microsomes and high speed supernatant
may indicate some breakage of mitochondria, although in a histochemical
study of succinate dehydrogenase in human skin, activ ity  was present
187in granules and also diffusely in the cytoplasm
D ifficu lty  was found in finding a suitable microsomal enzyme marker.
Glucose-6-phosphatase, a iliv e r microsomal marker^ was not detectable
in any fractions. Another live r microsomal marker, NADPH cytochrome 
197c reductase , was d if f ic u lt  to detect in homogenates. Nonspecific 
esterase activ ity  was investigated because i t  has been reported to be 
located mainly in the microsomes in live r^ 9^  and small in te s t in e ^ .
In both skin preparations the activ ity  was spread throughout the 
fractions, with a lo t of activ ity  being found in the high speed 
supernatant. That this was not due to cross-contamination of the 
microsomes and high speed supernatant fractions can be seen from the 
distribution of glucuronyltransferase and glutathione-S-transferase 
ac tiv ities . I t  may be that esterase activ ity  in skin is not confined 
to the endoplasmic reticulum or, from its  sim ilarity to the distribution  
of acid phosphatase, is of a lysosomal origin. With the problems 
encountered, with subfractionation of cutaneous lysosomal a c tiv itie s ,
a study of the distribution of an activ ity  alone is not suffic ient to 
classify i t  as being of a lysosomal origin. This problem highlights 
a drawback of the fractionation method adopted.
Glucuronyltransferase was fin a lly  chosen as a marker for the microsomal 
fraction. In live r the activ ity  for 4-methyl umbelliferone and bilirubin
i
have been considered to be as diagnostic for the microsomal fraction as
glucose-6-phosphatase^, although in the intestine some activ ity  for steroid
substrates has been found to be associated with the outer mitochondrial 
115amembrane . Glucuronidation is not an ideal marker because activation 
could occur during fractionation, however, both native and detergent 
activated preparations showed a similar distribution in both rat and 
mouse skin. The hairless mouse skin microsomes contained 61% of the 
ac tiv ity , but in the rat the skin microsomal fraction contained only 
half the ac tiv ity , however, considering these activ ities  were associated 
with 4% and 7% of the protein in the hairless mouse and ra t respectively 
i t  represents a considerable purification.
As in liv e r, and other organs, glutathione-S-transferase activ ity
was associated with the high speed supernatant. The enzyme was d if f ic u lt
to measure in rat homogenates due to its  low ac tiv ity .
The distribution of proteins showed marked differences from those reported 
for other organs. The percentage of protein recovered in the microsomes 
for skin was lower than that reported for rat liv e r, 19% ,^ and small
p e p
intestine, 17% , while the high speed supernatant had double the
percentage found in the other organs. I t  is uncertain whether this 
distribution is due to the presence of fractions of cells with a smaller 
percentage of endoplasmic reticulum or dilution by structural proteins 
found in skin.
3 . 3 . 1 . 3  C y t o c h r o m e  P - 4 5 0  s t a b i l i t y
The properties of cytochrome P-450 and its  presence in skin preparations 
have been discussed in Chapter 1. The compounds that were investigated 
as protectants in the present study are known to protect against 
cytochrome P-420 formation in liv e r, except for DMSO and Ficoll which
94have been reported to protect cytochrome oxidase in skin preparations . 
The integrity of cytochrome P-450 in the samples was measured by 
determination of enzyme activ ity  rather than spectral measurement 
because even i f  the enzyme was stable, the level of carbon monoxide 
complex would be expected to be near the lim its of detectability . The 
drawback of monitoring activ ity  of a particular substrate is that i t  may 
not represent a ll the cytochrome P-450 types present and i f  associated
r
with a stable form of enzyme would not detect the destruction of other
forms. However, as ethoxyresorufin deethylase activ ity  is thought to
be associated with the type(s) of hepatic cytochrome P-450 induced by
45polycyclic aromatic hydrocarbons , and as the constitutive ac tiv ity  in
274skin is reported to be similar to this type , ethoxyresorufin 
deethylase should be a good indicator of the integrity of the cytochrome 
P-450(s) present. The fact that none of the compounds investigated 
as stabilizers increased the detectable activ ity  of ethoxyresorufin 
deethylation could mean that the enzymes were being degraded by a 
pathway other than those inhibited by these compounds. That the
IA U/K\cU
experiments wtrere hepatic and skin preparations were mixed did not 
lead to a reduction in hepatic cytochrome P-450,could be because no 
breakdown occurred, or to different types of cytochrome being present 
in liver or to the presence of hepatic inhibitors of cytochrome P-450’s 
destructive factor(s). As no evidence of breakdown of cytochrome P-450 
could be observed, direct investigations into this specific subject
were terminated, however, as the results were inconclusive i t  was 
hoped further evidence on this subject might materialize in the 
course of other studies.
3.3.2 Skin Strips
That the breakdown of glucuronide in medium that had been incubated 
with skin strips was due to 3-glucuronidase was shown by its  pH 
dependency and inhibition by saccharic acid-1,4-lactone. Although this 
hydrolysis did not effect the measurement of products of 7-ethoxycoumarin 
or 7-hydroxycoumarin metabolism when incubated under the conditions 
used in this study, possible breakdown of metabolites in the medium must 
be considered and, i f  possible, checked for when using other substrates. 
Oxygen uptake was nearly linear over the hour measured, which indicated 
that the strips are viable over this time period. The linear dependence 
of activ ity  upon amount of skin strips present in the incubation 
demonstrates that quantitative measurements are possible in these 
preparations. Specific activ ities  were expressed on a dry weight basis 
because this obviated the necessity of accurate measurement of weight 
before the incubation which would be time consuming and possibly 
detrimental to the strips.
C H A P T E R  4 
THE HAIR CYCLE
4.1 INTRODUCTION
4.1.1 The Hair Cycle
Hair grows cyclically , with alternating periods of growth and quiescence.
During the growth phase fo llic le s  are said to be in anagen and during the
subsequent resting phase they are said to be in telogen. The transition
period is called catagen. When a quiescent fo ll ic le  grows again i t  forms
a new hair which either dislodges the old hair or grov/s alongside i t .
The pattern of growth and rest and the rate of growth vary from species
to species. In rats and mice frequent synchronous growth periods occur
in waves that move anteroposteriorly and ventrodorsally over the
animal body. In any specific area of the growth wave a ll of the fo llic le s
49 59are in the same growth phase * . The synchronism of these cycles
slowly breaks down over progressive cycles, until each fo ll ic le  has its  
own growth cycle that is largely independent of its  neighbours.
During early anagen the fo ll ic le  grows in length by extensive mitotic
activ ity  in the external sheath and the germ develops into a bulb which
encloses the dermal papilla and the new internal sheath forms. The
epidermis has been reported to be thicker during this period^. About
a third of the way through this phase the corium and adipose layers
increase two to three times their original thickness. This increase in
thickness is due to an increase in blood supply and tissue flu id  in
the corium, and to a tremendous accumulation of fa t in the cells of 
finthe adipose layer . At this stage the fo llic le s  have attained the ir  
fu ll length of about three to five times that of the telogen stage 
and there is a decrease in mitotic ac tiv ity . At this time the hair shaft 
begins to be formed. The bulb is now far down into the thickened 
adipose layer, in some cases v irtua lly  against the pannicuius
carnosus. During the la tte r two-thirds of anagen, which is the phase 
of hair growth, the corium and adipose layers maintain their thickness.
During catagen the club of the resting hair is formed. The bulb transforms
into a rapidly shortening epithelial strand and the whole fo ll ic le
shortens to less than one-third its  previous length. These processes
are completed in about two days and culminate in telogen, a stage in
which the fo ll ic le , with its  attached dermal papilla, comes to lie  well
up in the corium. These rapid changes are paralleled by changes in the
adipose and corium layers, which decrease to their telogen dimensions.
The sebaceous glands exhibit more variab ility  for any given stage than
do the hair fo llic le s  or the layers of the skin. Nevertheless, they
are generally large during telogen and early anagen and are reduced
finin size during the la tte r  portion of anagen and catagen .
4.1.2 Biochemical Changes During The Hair Cycle
A number of studies of the effect of the hair cycle on various enzymes 
have been reported, although these include only one investigation into 
a drug metabolizing ac tiv ity , namely a histochemical study of esterase 
activ ity  in mouse skin using 1-naphthol acetate as substrate^.
Activity was high in the resting hair fo llic le  which decreased during 
the growth phase. The activ ity  in the epidermis dropped during the 
transient hyperplasia in early anagen. In the same study the levels 
of succinate dehydrogenase were also reported. This activ ity  exhibited 
a reverse of the pattern described for the esterase activ ity .
The effect of the hair cycle on the metabolism of a number of steroids 
has been reported. A histochemical study in rat skin of dehydroepiandro-
sterone dehydrogenase showed activ ity  in the hypodermis in fibroblasts
and adipose tissue, especially around hair fo llic le s , in late anagen,
72catagen and early telogen . The highest activ ity  was during the phase
of greatest hair growth. Activity decreased in late telogen and early
anagen. The metabolism ofoestrone tooestradiol has been described 
220for ra t skin . In this study the skin was minced and then incubated
with the substrate. There was an increase in metabolism with the
progression of anagen, then a decrease through catagen and early
telogen. A similar study has been carried out on testosterone 
221metabolism . The 5-a-reductase activ ity  was maximal in the middle 
of anagen, decreased during the la tte r  part of anagen and catagen but 
manifested an increase during telogen. 17-3-Hydroxysteroid dehydrogenase 
activ ity  increased during the f ir s t  half of anagen and decreased through­
out catagen and telogen. Other activ ities  which have been reported to
53change during the hair cycle are NADH cytochrome C reductase , cytochrome
53 72oxidase , and glucose-6-phosphate dehydrogenase .
Studies have been carried out on the effect of the phase of the hair
cycle on the yield of tumours induced by 9,10-dimethyl-1 ,2-benzanthracene 
8 34in mice 9 . A  large yield of tumours was obtained when a single dose
of the hydrocarbon was deposited on the skin at the beginning of a
resting phase, but only a small yield of tumours occurred when the
carcinogen was applied at the beginning of a growth phase. An
explanation of this observation has been put forward based on the results
of a fluorescence miscroscopy study of 9 ,10-dimethyl-l,2-benzanthracene 
21in mouse skin : The fluorescence of the hydrocarbon in the sebaceous
glands and lower regions of the hair fo llic le s  persists about ten times 
longer in the resting phase than in the growth phase. I t  was postulated 
that the lack of tumour formation a fter the carcinogen was applied at.
the onset of the growth phase was due to the short retention of an 
adequate concentration of the carcinogen. No other studies have been 
carried out that could help explain these observations, for example, 
a change in the metabolism of the hydrocarbon during the hair cycle.
With the large structural changes and evidence of enzyme changes i t  
is important to know the chronology of the hair cycle before embarking 
on a biochemical investigation of the skin. To this end a study of 
the hair cycle in rat and mouse was undertaken.
4.2 RESULTS
4.2.1 Investigation of the Chronology of the Hair Cycle
Figures 4.1 to 4.6 show the course of the hair cycle in the ra t, as 
shown by histological investigation. Figures 4.1 to 4.3 are a ll of the 
same magnification and are of rats of the ages 15, 25 and 35 days 
respectively. In the 15 day old rat the skin was in anagen, with the 
hair fo llic le s  stretching far down into the hypodermis. Ten days la te r, 
in the 25 day old ra t, the skin had passed through catagen and was in 
telogen. The hair fo llic le s  had degenerated and did not reach fa r past 
the sebaceous glands. There was a dramatic decrease in the thickness 
of the skin to under half of that found at 15 days old. This was 
accounted for mainly by a loss of fa t tissue. In the 35 day old ra t, 
anagen was just beginning. The skin was slightly  thicker and the bulb 
that contained the dermal papilla could be seen. This is shown well 
in Figure 4.4 which is a ;4 times magnification of a hair fo ll ic le  in 
Figure 4.3. Ten days la ter at 45 days old the skin was again in anagen. 
This is shown in Figure 4.5 which is at four-tenths the magnification 
of Figures 4.1 to 4.3, showing how thick the skin had become compared
to the earlie r ages, even the preceding anagen phase at 15 days old.
Figures 4.6 to 4.10 depict the hair cycle in Balb/c mice and are a ll 
of the same magnification. Figure 4.6 is of 25 day old mouse skin, 
showing i t  to be in early anagen with the bulbs forming at the base of 
the hair fo llic le s . At 35 days old (Figure 4.7) the hair fo llic le s  
were fu lly  grown and the skin was almost twice as thick. Again a great 
increase in the amount of fa t could be observed. At 45 days old (Figure 
4.8) the skin had passed through catagen and was in telogen, with the 
hair fo llic le s  being much shorter and the skin thinner. The skin was 
s t i l l  in telogen at 55 days (Figure 4 .9 ). At 65 days old (Figure 4.10) 
the skin was shown to be in early anagen,with the fo llic le s  in the process 
of growing.
The hair cycle in the hairless mouse is shown in Figures 4.11 to 4.16. 
Because of the sparsity of hair fo llic le s , histological examination did 
not show the hair cycle clearly, therefore, pictures of the mice were 
taken. As discussed in the Introduction, the changes in the fo llic le s  
occur in waves that move anteroposteriorly. This can be seen clearly  
in the 14 day old hairless mouse (Figure 4.11). The young mice have at 
f ir s t  a normal pelage, which is lost during the f ir s t  fu ll hair cycle.
As catagen starts the head f ir s t  loses its  hair, then hair loss occurs 
in a wave down the rest of the body. Figures 4.11 shows the half-way 
stage. At 25 days (Figure 4.12) catagen had been completed and the 
skin was in telogen, with an almost complete loss of hair except for 
the whiskers. At 35 days (Figure 4.13) anagen had started, although 
fewer hairs were grown. At 45 days (Figure 4.14) catagen was again 
starting, with the head losing the hair f ir s t .  At 55 and 65 days 
(Figures 4.15 and 4.16 respectively) the skin was in telogen with a 
very sparse covering of hair. The next hair cycle in hairless mice
FIGURE 4.1
15 Day Old Rat Skin (microscope magnification x l00)
FIGURE 4.2
25 Day Old Rat Skin (microscope magnification xlOO)
FIGURE 4.3
35 Day Old Rat Skin (microscope magnification xlOO)
FIGURE 4.4
45 Day Old Rat Skin (microscope magnification x400)
FIGURE 4.5
55 Day Old Rat Skin (microscope magnification x40)
FIGURE 4.6
25 Day Old Mouse Skin (Balb C) (microscope magnification xlOO)
FIGURE 4.7
35 Day Old Mouse Skin (Balb C) (microscope magnification xlOO)
FIGURE 4.8
45 Day Old Mouse Skin (Balb C) (microscope magnification xlOO)
FIGURE 4.9
55 Day Old Mouse Skin (Balb C) (microscope magnification x 100)
FIGURE 4.10
65 Day Old Mouse Skin (Balb C) (microscope magnification xlOO)
FIGURE 4.11
14 Day Old Hairless Mouse
FIGURE 4.12
25 Day Old Hairless Mouse
FIGURE 4.13
35 Day Old Hairless Mouse
FIGURE 4.14
45 Day Old Hairless Mouse
FIGURE 4.15
55 Day Old Hairless Mouse
FIGURE 4.16
65 Day Old Hairless Mouse
resulted in even fewer hairs being formed and in an almost complete 
degradation of the hair fo llic le s .
4.2.2 Enzyme Activity during the Hair Cycle
Table 4.1 shows the enzyme activ ities  in the post mitochondrial supernatant 
of rats at different stages in the hair cycle. 7-Ethoxycoumarin deethylase 
was non-detectable at any age. The esterase activ ity  increased from the 
15 day old to the 30 day old ra t, but did not significantly decrease 
on re-entering the growth phase. The glutathione-S-transferase activ ity  
remained unchanged.
Table 4.2 shows the enzyme activ ities  in the post mitochondrial supernatant 
of Balb/C mouse skin at differing stages of the hair cycle. No distinct 
pattern was observed in any of the three activ ities  monitored. Table 4.3 
shows the results of a similar study with hairless mice. 7-Ethoxycoumarin 
deethylase showed a tendency to increase- in the anagen phase, although 
i t  was not significant. No distinct patterns were shown with the 
esterase or glutathione-S-transferase ac tiv itie s .
Table 4.4 shows the results of 7-ethoxycoumarin metabolism in skin strips 
from rat and mouse. Both types of mice showed a tendency for ac tiv ity  to 
decrease with age, regardless of the phase of the hair cycle. The rat 
showed a decrease in activ ity  at 45 days with respect to the activ ities  
at 15 and 30 days, which were similar.
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4 .3  DISCUSSION
4.3.1 Chronology of the Hair Cycle
48The hair cycle observed in the rat agrees with that observed by Butcher . 
Butcher did not specify which strain of rat he used, only that i t  was 
albino. As in this study, 15 day old rat skin was in anagen and 
25 day old rat skin in telogen. Butcher described the growth of the 
hair fo llic le s  beginning at 32 days, agreeing with our study with 35 
day old rat skin being in early anagen. In both studies at 45 days old 
the hair fo llic le s  were in anagen.
finThe hair cycle has been described for C57Bl/6ch mice . Although the
lengths of various phases were reported they were not identified with
the age of the mice and so no direct comparison with our study can be
made. The hair cycle in the hairless mouse has been more fu lly  
142reported . The results reported agree well with the chronology of 
the hair cycle observed in our study. Therefore, as far as can be 
ascertained the hair cycles observed in the animal strains in this 
study agree with previous reports. I t - is  interesting to note the 
difference in the chronology of the hair cycle between the Balb/c and 
hairless mice. This raises the question as to whether sim ilar differences 
occur between other hairy strains of mice, or i f  i t  is just a difference 
between hairy and hairless mice. Such a comparative study of the 
hair cycle between different strains of mice has not been reported 
previously.
4.3.2 Enzyme Activities during the Hair Cycle
The only change in activ ities assayed in the post mitochondrial supernatant
from the skin of rats of different ages was the esterase a c tiv ity . This 
may well re flec t a developmental pattern rather than a dependency on 
the phase of the hair cycle as the values were low in the f ir s t  growth 
phase but similar in the subsequent resting and growth phases. The other 
activ ities  in the rat and those in the mice did not exhibit any 
fluctuations with the hair cycle. The results from the esterase 
activ ities  are at variance with the histological study of esterase activ ity  
during the mouse hair cycle previously discussed^. I t  is possible that 
activ ities  increase in one part of the skin and decrease in other parts 
as the hair cycle proceeds and, therefore, giving the appearance of a 
constant activ ity  in the preparations used in this study.
As the skin thickens during anagen, an increase in protein would be 
expected. Therefore, the fact that the specific activ ities  did not 
a lter would indicate an increase in the total drug metabolizing capacity 
of the skin, but as can be seen from these results, there was not a specific 
increase in the enzymes assayed as compared to other proteins present in 
the supernatant. The results could be interpreted such that the hair fo llic le s
i
do not contribute much to the skins capacity to metabolize the substrates used.
A pattern was apparent with the 7-ethoxycoumarin deethylase activ ities  
in skin strips. As the specific activ ities  are expressed on a dry weight 
basis, when the skin is in the growth phase the large amount of non­
active tissue would tend to lower the resulting specific a c tiv ity . This 
could explain the low activ ity  of the 45 day old rat compared to the 15 
and 30 day old rats. Even i f  this did not account for a ll the differences, 
there is s t i l l  no clear pattern of values changing in concert with the 
different phases of the. hair cycle in either the mouse or the ra t.
Even though no changes were apparent with the activ ities  investigated,
other activ ities  could change with the hair cycle and,; therefore, 
the ages of the animals and phase of the hair cycle should always be 
defined and kept constant in any biochemical study of the skin.
The present study did show some species and strain differences. The 
activ ities  of 7-ethoxycoumarin deethylase were, in descending order, the 
hairless mouse > Balb/c mouse »  ra t, and that of the glutathione-S- 
transferase, Balb/c mouse 5 hairless mouse > ra t. The series for 
the esterase activ ities  was. the opposite to that for the deethylase 
activ ity  being, rat > Balb/c mouse > hairless mouse. The re lative ly  
high levels of 7-ethoxycoumarin deethylase and glutathione-S-transferase 
activ ities in the hairless mouse again tends to indicate that the 
hair fo llic le s  are of limited importance for these a c tiv itie s .
C H A P T E R  5 
OXIDATIVE DRUG METABOLISM IN SKIN MIGROSOMES
5 .1  INTRODUCTION
Skin is known to contain inducible mixed function oxidase ac tiv ity .
The activ ity  is low on a whole organ basis relative to liv e r , even
when fu lly  induced, therefore, the contribution of skin to the total
oxidative metabolism of most xenobiotics is probably quite small.
However, the importance of drug metabolism cannot be judged by the 
amount of xenobiotic metabolized. For example, polycyclic aromatic hydro­
carbons need oxidative activation in order to express their carcino­
genic properties. Although skin has a much lower capacity to metabolize 
these compounds than liv e r, i t  is the more susceptible of the two 
organs.
The literature  on cutaneous mixed function oxidase levels and induction 
has been reviewed in Chapter 1. Table 1.1 shows some of the compounds
known to induce AHH in skin. In an industrial society, contact between
skin and an inducer is more of a certainty than a possibility. The
widespread exposure to inducing agents, in conjunction with the presence 
of inducible forms of cytochrome P-450, which can influence the toxicity  
of compounds to which skin is a target organ, makes the study of metabolism 
of xenobiotics in skin an important area of investigation.
Three compounds, apart from solvents, were used as inhibitors in the 
present study, metyrapone (2-m ethyl-l,2-di-3-pyridyl-l-propane),
5,6-benzoflavone and 7,8-benzoflavone. Inhibitors are important tools 
in characterizing the types of cytochrome P-450 present, especially 
when low levels of activ ity  restricts the range of substrates which 
can be studied. Metyrapone was f ir s t  known as an inhibitor of adrenal
1 C C  O Q Q
steroid Ilf-hydroxylase and other steroid hydroxylases . I t  has
162 198since been widely used as an inhibitor in drug metabolism studies 9
199 129and is a ligand of both the fe rric  and ferrous forms of hepatic
cytochrome P-450. The binding of metyrapone to reduced hepatic
cytochrome P-450 is increased by phenobarbitone pretreatment but
147decreased by 3-methylcholanthrene pretreatment . 5,6-Benzoflavone
and 7,8-benzoflavone are isomers related to the flavonoid compounds
that occur widely in nature as pigments. 7,8-Benzoflavone has been
used to distinguish between two types of hepatic AHH. This compound
strongly inhibits hepatic AHH from polycyclic hydrocarbon-treated
rats, but has no inhibitory effect when the enzyme source is derived
104 273from control or phenobarbitone induced animals 9 .
I t  is well documented that water soluble solvents can affect hepatic
cytochrome P-450 ac tiv ities , such as enhancement of aniline hydroxylase
9 135by acetone and ethanol inhibition of dichioronitroanisole demethylation ,
229 273aniline hydroxylase , and benzo[a]pyrene hydroxylase . There is
evidence that induction of drug metabolizing enzymes may change their
sensitivity to solvent inhibition. Thus phenobarbitone induction
135decreases ethanol sensitivity of dichloronitroanisole demethylase and
2733-methylcholanthrene pretreatment decreases AHH sensitivity to ethanol 
Therefore, solvent inhibition may be a useful parameter in character­
izing mixed function oxidase dependent ac tiv itie s .
5.2 RESULTS
5.2.1 Induction
Figures 5.1 and 5.2 show the relationship between 7-ethoxycoumarin
deethylase and protein concentration using rat and hairless mouse
skin microcomes. After intraperitoneal administration of 5,6-benzoflavone,
induction was observed in the ra t, furthermore there was a linear 
relationship with protein up to 0.75 mg protein per ml, the activ ity  
then dropped sharply with increasing protein concentration. The 
same type of effect was seen after topical administration of
5.6-benzoflavone, with the linear relationship between protein and 
activ ity  ceasing at about the same protein concentration. After 
induction by intraperitoneal administration of 3-methylcholanthrene, 
the activ ity  was linear with protein up to the highest protein 
concentration tested, that is 2.4 mg protein per ml. In hairless 
mouse skin microsomes (Figure 5 .2 ), after topical induction by
5.6-benzoflavone, linearity  between protein and enzyme activ ity  was held 
until approximately 2 mg protein per ml, while after intraperitoneal 
induction by 5,6-benzoflavone the relationship was s t i l l  linear at the 
highest concentration tested, that is nearly 3 mg protein per ml.
Differing amounts of 7-hydroxycoumarin and differing protein concentr­
ations of rat skin microsomes were incubated under the same conditions 
as the 7-ethoxycoumarin deethylase assay. No decrease in the amount 
of 7-hydroxycoumarin extracted was evident, indicating that i t  was not 
being bound or further metabolized. The decreasing 7-ethoxycoumarin 
deethylase activ ity  with increasing protein concentration, therefore, 
appears to be due to a factor affecting the deethylation reaction, 
rather than an a rtifac t in the measurement of the 7-hydroxycoumarin 
produced. Further investigation of 7-ethoxycoumarin deethylase in
5.6-benzoflavone induced rat skin microsomes was carried out at low 
protein concentrations, under which conditions the activ ity  was related 
linearly to protein concentration. As w ill be discussed in detail 
la te r, i t  was considered that the drop in activ ity  could be due to 
residual levels of 5,6-benzoflavone being present in the microsomes 
causing an inhibition e ffect, therefore studies on inhibition were
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Relationship between proteir^\and 7-ethoxycoumarin deethylase activ ity  
in hairless mouse skin microsomes
•  5,6-benzoflavone induced (topical)
■ 5,6-benzoflavone induced (intraperitoneal)
carried out using microsomes from 3-methylcholanthrene induced 
rats.
Table 5.1 shows the control and induced deethyl ation activ ities  in 
rat and hairless mouse skin microsomes. Control levels of 7-ethoxy- 
coumarin deethylase were not detectable in the rat (that is >10  pmol/ 
hr/mg protein). Ethoxyresorufin deethylase was barely detectable 
in any rat skin preparations. After intraperitoneal administration 
of 5,6-benzoflavone there appeared to be some activ ity  at low protein 
concentrations, but this was too small for accurate measurement. As 
the protein concentration was increased the activ ity  became non- 
detectable. Fluorescence of resorufin was measured over the same range 
of protein concentrations and increased quenching on elevating the 
protein concentration could not account for the apparent disappearance 
of ac tiv ity . A similar phenomenon to the drop in 7-ethoxycoumarin 
deethylase activ ity  with protein concentration, that is inhibition  
by residual 5,6-benzoflavone, may well have been the cause.
Since the control levels of 7-ethoxycoumarin deethylase are non- 
detectable in the ra t, the induced activ ities  must represent a large 
fold increase, showing the rat to be very responsive to the inducers 
used. The most effective route and compound was 5,6-benzoflavone 
given intraperitoneally. Topical application of 5,6-benzoflavone 
and intraperitoneal administration of 3-methylcholanthrene were about 
equal in effect. The dosage regimens are as described in Chapter 2.
The hairless mouse exhibited higher basal levels but lower responsiveness 
to inducers than the ra t. Only topical application of 5,6-benzoflavone 
brought about a rise in ethoxyresorufin deethylase, with a 2.2 fold
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increase over control. Ethoxyresorufin deethylase activ ities  in 
induced skin microsomes sh.owed a pronounced lag phase of about two 
minutes. No such lag phase was noticeable in microsomes from control 
animals. Intraperitoneal administration of inducers had l i t t l e  effect on 
7-ethoxycoumarin deethylase, no change was shown with 3-methylcholanthrene 
and only a 1.3 fold rise with 5,6-benzoflavone. Topical application 
of 5,6-benzoflavone resulted in a 3.6 fold increase in 7-ethoxycoumarin 
deethylase ac tiv ity . The induction pattern is , therefore, quite 
different to that shown by the ra t. Hairless mouse hepatic 
ethoxyresorufin deethylase induction was also studied. As shown in 
Table 5.2, 5,6-benzoflavone induction by intraperitoneal administration 
led to a 5.5 fold increase over control values.
Figure 5.3 shows the skin microsomal protein patterns produced by 
polyacrylamide gel electrophoresis. For comparison live r microsomes 
from rats and hairless mice pretreated with corn o i l ,  saline, pheno­
barbi tone, 3-methylcholanthrene, or isosafrole were run alongside 
control and induced rat and hairless mouse skin microsomes. The bands 
within the molecular weight range of 50,000 to 56,000 have been 
reported to contain the hepatic cytochrome P-450 proteins. In the ra t, 
phenobarbitone induced in live r bands in the molecular weight range 
of 50,000 to 53,000. 3-Methylcholanthrene induced, in liv e r , a band 
of higher molecular weight, approximately 56,000 and isosafrole an in te r­
mediate band with a molecular weight of about 54,000. A similar pattern 
was shown for the mouse live r proteins, but the difference between
3-methylcholanthrene and isosafrole was less marked than in the ra t.
No obvious difference between the skin protein profiles was visible  
in the molecular weight region of 50,000 to 56,000 between control and 
induced samples from either rat or hairless mouse.
FIGURE 5.3
Polyacrylamide Gel Electrophoresis o f L iver and Skin Microsomes 
Conditions as in  Materials and Methods. M igration from top to bottom. 
Wells 1, 2, 3 and 18, marker prote ins.
4-8 Rat hepatic microsomes : 4 ,phenobarbitone; 5 ,sa line ; 6 ,corn o i l ;  
7,3-methylcholanthrene; 8 , isosa fro le .
9,10 Rat skin microsomes; 9 ,corn o i l ;  10,3-methylcholanthrene.
11-5 Hairless mouse hepatic microsomes:
11,phenobarbitone; 12,sa line ; 13,corn o i l ;  14,3-methylcholanthrene;
15,isosa fro le .
16,17 Hairless mouse skin microsomes:
16,acetone; 17,5,6-benzoflavone.
Pre-treatment Ethoxyresorufin Deethylase 
nmol/min/mg protein
Corn Oil
5,6-Benzoflavone
0.075+0.025 
0.41 ±0.08f
TABLE 5.2
Induction of Hepatic Hairless Mouse Ethoxyresorufin Deethylase by
5,6-Benzoflavone
Inducer was administered by intraperitoneal injection. Results are! 
expressed as mean and standard deviation of three experiments. 
f  p<0.05.
Species Cytochrome bg (pmol/mg protein) 
Control Induced
Rat
Hairless Mouse
30±8
62±11
27±6
73±9
TABLE 5.3
Apparent Cytochrome bg Concentrations in Skin Microsomes 
Rat induced with 3-methylcholanthrene (intraperitoneal) and the 
hairless mouse with 5,6-benzoflavone (top ical). Results are expressed 
as mean and standard deviation of three experiments.
Attempts to measure skin cytochrome P-450 by spectral detection of the 
carbon monoxide complex are shown in Figures 5.4, 5.5 and 5.6. In 
a ll samples the presence of haemoglobin was indicated by the peak 
at 420 nm after bubbling the sample cuvette with carbon monoxide.
After reduction of both cuvettes with sodium dithionite, the only 
discernible peak at 450 nm was in microsomes from hairless mice 
topically pretreated with 5,6-benzoflavone. In a ll preparations 
there was an apparent increase in absorbance at the lower wavelengths 
after sodium dithionite reduction, thereby making the baseline askew.
This made the estimation of cytochrome P-450 concentration by measure­
ment of the difference in absorption between 450 nm and 490 nm inaccurate.
This increase in absorbance at the lower wavelengths may be a
cflp//i£y
characteristic of the spectrophotometerstryiftg to cope with very turbid 
samples rather than an actual absorbance change in the microsomes.
The apparent cytochrome bg concentration did not change on pretreatment 
of either hairless mouse or rat (Table 5 .3 ). The peak at 556 nm in the 
NADH reduced versus oxidized spectra, associated with cytochrome bg, 
was only visible in the hairless mouse preparations (Figure 5 .8 ). The 
in ab ility  to detect this peak in the rat preparations (Figure 5.7) 
was probably due to the low levels of cytochrome bg present.
5.2.2 NADPH Cytochrome C Reductase
Studies on NADPH cytochrome c reductase were complicated by a non-linear 
relationship between activ ity  and protein concentration in both 
hairless mouse and rat skin microsomes, as shown in Figure 5.9. 
Pretreatment of the animals had no effect on these a c tiv itie s , neither 
did addition of 2 mM FMN or FAD. Furthermore, increasing the concen­
tration of NADPH or cytochrome c in the incubation had no effect on
0 005 A
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i
500
FIGURE 5.4 _ ................
Difference Spectra of 3-Methylcholanthrene Induced Rat Skin Microsomes
(a) Carbon monoxide + dithionite in sample cuvette versus dith ionite  
in reference cuvette
(b) Carbon monoxide in reference cuvette only 
Protein concentration = 1.4 mg/ml
400 450 500
nm
FIGURE 5.5
Difference Spectra of Control Hairless Mouse Skin Microsomes 
Legend as in Figure 5.4 except that protein concentration = 1.5 mg/ml
0 0 0 5 A
400 450 500
nm
FIGURE 5.6
Difference Spectra of 5,6-Benzoflavone Induced Hairless Mouse Skin 
Microsomes
5,6-Benzoflavone administered topically . Legend as in Figure 5.4 except 
that protein concentration = 1 . 7  mg/ml
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FIGURE 5 . 7 --------
Oxidized Versus NADH Reduced Difference Spectra of Control Rat Skin 
Microsomes
Protein concentration 1.4 mg/ml. Conditions as in Materials and Methods
■
400 450
0 0 0 5 A
550 600
FIGURE 5.8
Oxidized Versus NADH Reduced Difference Spectra of Control Hairless Mouse 
Skin Microsomes
Protein concentration 1.7 mg/ml. Conditions as in Materials and Methods.
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FIGURE 5.9
Relationship between protein and NADPH cytochrome c reductase activ ity  
in rat and hairless mouse skin microsomes. Conditions a'sin Material 
and Methods
■ Rat skin microsomes 
•  Hairless mouse skin microsomes
the ac tiv ity , which indicated that neither of these were lim iting.
Use of potassium ferricyanide as an alternative electron acceptor 
proved impracticable because the control non-enzymic rate was so high 
that the influence of the enzyme could not be measured accurately.
The NADPH u tiliza tio n  in the incubation was investigated. A decreased 
NADPH level of 0.1 mM was used to reduce the absorbance at 340 nm and so 
enable monitoring at this wavelength. The ratio of moles of cytochrome 
c reduced to moles of NADPH oxidized at the protein concentrations of 
0.04, 0.08 and 0.16 mg.protein per ml were 1.03, 0.96 and 1.08 
respectively. Therefore, the oxidation of NADPH exhibited a similar 
non-linearity with protein concentration to the reduction of cytochrome c.
5.2.3 Inhibition
The effect of water-soluble solvents on 7-ethoxycoumarin deethylase 
activ ity  was investigated primarily because solvents are useful carriers 
for the introduction of water-insoluble inhibitors, such as the benzo- 
flavones, into incubations. The f ir s t  solvent investigated was dimethyl 
formamide (DMF). Figure 5.10 shows the effect of various concentrations 
of DMF on control hairless mouse and induced rat skin microsomal 
a c tiv itie s . The ra t was only sensitive a t the highest concentration 
of DMF used, that is 1.0% v/v, while the hairless mouse ac tiv ity  was 
inhibited by 25% at the lowest concentration used, that is 0.1% v/v.
A number of other solvents were tested at a concentration of 0.1% v/v, 
on control and induced hairless mouse and induced rat skin microsomes.
The results are shown in Table 5.4. The rat skin deethylase was insen­
sitive to a ll solvents except for ethanol. Hairless mouse a c tiv itie s , 
both control and induced, were inhibited by a ll five solvents investigated.
■f—
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FIGURE 5.10
Effect of DMF on 7-ethoxycoumarin deethylase activ ity  in rat and hairless 
mouse skin microsomes. Conditions as in Materials and Methods. Points 
represent mean of two experiments.
*  Rat (3-methylcholanthrene induced) 
■ Hairless mouse (control)
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This shows a clear difference between the 7-ethoxycoumarin deethylase 
in hairless mouse and rat skin microsomes.
A consequence of the sensitivity of the hairless mouse deethylase 
was that solvents could not be included in benzoflavone inhibition  
experiments. Metyrapone studies were unaffected as this was added in 
an aqueous solution. To overcome the solvent problem with benzoflavones, 
aliquots of the compounds in acetone were put into the incubation vessels 
before anything else was added, and the acetone blown o ff. To ascertain 
whether the benzoflavones were going into solution or adhering to the 
glass they were added both ind irectly, as above, and d irectly  to rat 
skin incubations (where acetone is not inhibitory) and the deethylase 
activ ity  measured. Both methods gave similar results, so this method 
of introducing the benzoflavones to hairless mouse skin incubations 
was used routinely.
5,6-Benzoflavone and 7,8-benzoflavone showed similar inhibitory patterns. 
All preparations were sensitive to these isomers, with the induced 
hairless mouse and rat preparations being very similar in their suscep­
t ib i l i t y .  Control hairless mouse was less sensitive to both benzo-
- f iflavones at a concentration of 1x10 M, but the extent of inhibition
at 1x10’  ^ M was similar to the other preparations. Metyrapone had a
similar effect on a ll preparations, showing strong inhibition at a
-3concentration of 1x10 M. These results are summarized in Table 5.5.
5.3 DISCUSSION
5.3.1 Induction
The complex relationship between protein concentration and 7-ethoxycoumarin
In
hi
bi
to
r 
Pe
rc
en
ta
ge
 
of 
Co
nt
ro
l 
7-
Et
ho
xy
co
um
ar
in
 
De
et
hy
la
se
 
A
ct
iv
ity CD£CD r—£- toxz CD■p £
£ Oto •P-p r— •r—
to O i-a: sz CDo Q.
1— tO
>> S-J£ ■P-P £
CD •i—
z :* —'1
CO
CD
£o
>
<T3
N  * r-
£  Q.<U oCQ h-
CD I — '
CO CO3 "
O  LO
CO
CO
CD
CD p—
£ (O
O o
-P •1—
CD Q .
O O
<C
CO o o CO
COr— r— p— I—
+1 +1 + i +1 +1CO r— o
CO CO CO CO CM
CO-P
£CD
CO CO cr> CO lo S-
+1 +i +i +i +i CDcn cn co CO Q-CO CO CM n-* r— X
CD
CDcn CDCD S-
E .£o •Pcn
O 4-S- Oo•1— £
z O
O •r“
co ■— r^. £ -P
+t +1 +1 +i +t •r~ to1— CM CO co 00 -X •1—
co CO CO CM CO >CD£ ■o•p~
■a' CD s-cn to<o *oi— £
>y to-p-p cn
CD
z  z z  z z 03 *oa £
co n>. co n- CO fOi i i i i £
o  o o  o o •r~ £r— r— p— r— r— S- <ofO CDE E3
O cnU to
>>X -a
o CDx : cn-p cnUJ CD
CD CD i s-£ £ r^. o .
O O X
> > 4- CDto to Pp— r— CD
4- 4— CD £ S-
o O £ LO O fON M O • *r-i£ £ o . LO -P cn
CD CD to •r— ■pCQ CQ S- LQ X) r—
1 1 >> _1 *p- 3CO 00 -P CQ -£ cnn #1 CD <C £ CDLO z: h - QO
deethylase activ ity  showed that care must be taken when selecting the 
incubation conditions for rat skin microsomes after pretreatment with
5,6-benzoflavone. The decrease in ac tiv ity  seen with increasing 
protein concentration could be due to binding of the substrate or 
inhibition by residual amounts of 5,6-benzoflavone being present in 
the microsomes. Binding of the product of the reaction was shown not 
to occur. I t  is unlikely that binding of the 7-ethoxycoumarin is the 
cause, as microsomes from 3-methylcholanthrene treated rats, which 
might be expected to show comparable binding capacity, did not show 
this effect and neither did control or induced hairless mouse micro­
somes. Residual amounts of 5,6-benzoflavone being present is more 
like ly  to be the cause of the drop, in ac tiv ity . As the protein 
concentration increases so would the 5,6-benzoflavone and an
inhibitory concentration would be b u ilt up. The inhibition studies .
d eetrl
showed that 5,6-benzoflavone was a potent inhibitor of 7-ethoxycoumarin\
- f iin rat skin, inhibiting by about 70% at 1x10” M. In this context i t  
is worth noting that the total amount of 5,6-benzoflavone applied to 
the skin on topical administration was 11 jumoles.
The reason why the rat but not the mouse showed a non-linear relationship 
between protein concentration and enzyme activ ity  when both activ ities  
were approximately equal in sensitivity to inhibition by 5,6-benzo­
flavone may be that rat skin has a higher lip id  content than mouse skin 
(because of this more benzoflavone may accumulate in rat skin which 
could be released on homogenization). The amount pelleted with the 
microsomes would depend on the amount of lip id  associated with this 
fraction which would regulate the amount of 5,6-benzoflavone, which is 
hydrophobic, dissolved in i t .  Whatever the reason, the possibility of 
this phenomenon occurring must be considered when carrying
out induction experiments in the ra t. With low activ ities  i t  is 
tempting to use high protein concentrations which in this case could 
lead to a high degree of inhibition and possible non-detection of 
enzyme ac tiv ity .
Induction studies in mice are complicated by the fact that mouse 
strains d iffe r greatly in their basal and induced levels of cytochrome 
P-450 dependent enzyme activ ities  in hepatic and extrahepatic
n c  I C Q  I Q f i
tissues * * . There appear to be two major groups of mouse
strains in which hepatic AHH is either inducible or not inducible
1Dfi 254-by polycyclic aromatic hydrocarbons 9 . In the skin of strains
in which liver is not responsive to polycyclic aromatic hydrocarbon
inducers, i t  has been reported that AHH activ ity  increases a fter
topical application of benz[a]anthracene^’ ^  or methyl cholanthrene^’
although the increase is only a third to a f if th  of that in responsive 
195 274strains ’ . In the present work a 5.5 fold increase of hepatic
ethoxyresorufin deethylase, an activ ity  similar in characteristics 
45to AHH , after 5,6-benzoflavone induction was observed indicating 
that the hairless mice are responsive. However, this is not as great 
an increase as shown by C57B1/10 mice (a strain that is known to be
very responsive) in which there was a 14.5 fold increase in ethoxy-
92resorufin deethylase after 3-methylcholanthrene pretreatment .
That 7-ethoxycoumarin deethylase activ ity  in hairless mouse skin was
not changed by intraperitoneal administration of 3-methylcholanthrene
agrees with a report that topical application of this compound fa iled
215to induce this activ ity  in mouse skin . 5,6-Benzoflavone did raise 
hairless mouse activ ity  in skin, particularly when given topically.
These results are similar to those reported for AHH in mouse skin as 
regards 5,6-benzoflavone being a more effective inducer than 3-methyl-
cholanthrene, but are the reverse as regards the efficiency of the
105two routes of 5,6-benzoflavone treatment on AHH induction .
Only topical application of 5,6-benzoflavone brought about an increase
of ethoxyresorufin deethylase in the hairless mouse skin. The lag
period seen in the induced activ ity  may be accounted for i f  one
assumes that ethoxyresorufin its e lf  is not the substrate for cytochrome
P-450 mediated deethylation. I t  has been reported that ethoxyresorufin
is rapidly reduced in the presence of NADPH and cytochrome P-450 
266reductase . This reaction is independent of cytochrome P-450 and has 
been observed in microsomes and reconstituted systems of purified  
proteins. Because of the fast rate of this reaction one might postulate 
that the reduced compound is the actual substrate for the deethylation, 
with the deethylated product undergoing spontaneous reoxidation to 
resorufin. Therefore, the lag phase could be due to insuffic ient 
ethoxyresorufin being reduced to saturate the enzyme.
The rat showed a different pattern of induction of 7-ethoxycoumarin
deethylase, with intraperitoneal administration of 5,6-benzoflavone
as the most effective means of induction. All activ ities  were lower
than the corresponding ones in hairless mouse skin, but the response
to inducers was greater. This greater responsiveness of ra t than mouse
to inducers has been observed also for AHH, with an increase of 15-fold
235after intraperitoneal induction by 3-methylcholanthrene in the ra t
compared to a 2-fold increase in mouse after a similar induction 
274regimen . Comparison between rat and mouse AHH values in the 
literature  is d iff ic u lt  because of differing activ ities  between strains. 
The values from six mouse strains have been reported to vary between
27416-120 pmoles/mg protein/hr when assayed in the whole skin homogenate .
The value of 25 pmol/mg protein/hr has been reported for AHH in rat
26whole skin homogenate . The non-detectability of control ra t 7-ethoxy- 
coumarin deethylase activ ity  in this study shows a larger difference 
between the two species for this activ ity  than those quoted for AHH.
The difference in the efficacy of the two routes of induction between
rat and hairless mouse could indicate differences in the major sites
of oxidative metabolism and/or distribution of the inducer. In the
mouse, AHH activ ity  has been reported to be higher in the epidermis,
2 255 275both in control and induced animals 9 9 . In this investigation
(Chapter 6) control hairless mouse 7-ethoxycoumarin deethylase activ ity  
was found to be higher in the epidermis, while in the rat the only 
detectable activ ity  was in the dermis (or its  associated appendages), 
although the rat had been induced so as to enable detection of the 
a c tiv ity .. Remembering that the epidermis has no blood supply, a fter  
intraperitoneal injection the inducer would have to diffuse into the 
epidermis, whereas i t  would be taken directly  to the hair fo llic le s , 
sweat glands, and a ll through the dermis which has a good blood supply. 
Therefore, this route would be expected to favour induction in the ra t.
On topical induction the inducer f ir s t  has to diffuse into and across 
the epidermis which, therefore, gets the greatest exposure to the inducer. 
This route could be expected to favour induction in the mouse rather 
than the ra t.
A clear peak at 450 nm, characteristic of the reduced cytochrome P-450 
carbon monoxide complex, was only observed in hairless mouse microsomes 
after induction by topical administration of 5,6-benzoflavone. The 
peak at 420 nm could mainly be accounted for by the presence of haemo­
globin, suggesting that in this preparation the cytochrome P-450 was
not being broken down to cytochrome P-420 to any great extent. No 
trough at 445 nm was observed in any preparation, indicating that 
cytochrome oxidase contamination was not interfering significantly.
The apparent levels of cytochrome bg were not affected by pretreatment
in either the rat or hairless mouse. I t  was not certain that a ll the
absorbance change on reduction with NADH was due to cytochrome bg.
Mitochondrial fractions of rat liver contain at least three kinds of
cytochromes which resemble spectroscopically microsomal cytochrome bg
99and which have been often referred to erroneously as cytochrome bg .
Two of them are thought to be associated with sulphate oxidase which is
located in the space between the outer and inner membranes of the 
99 141mitochondria 9 . The third component is located on the outer
surface of the outer membrane and is only distinguishable from micro­
somal cytochrome bg by its  amino acid sequence and in a b ility  to react
go
with the specific antibody against the microsomal cytochrome . The 
subcellular fractionation studies (Chapter 3) employed succinate 
dehydrogenase as a mitochondrial marker. This enzyme is located in the 
inner membrane and, therefore, the distribution of the outer membrane 
and the components usually located between the two membranes in our 
microsomal preparation is not known. Until these distributions have 
been studied and the presence, or otherwise, of the cytochrome bg like  
proteins shown in skin, apparent values of microsomal cytochrome bg 
must be suspect.
The hepatic microsomal protein patterns after polyacrylamide gel electro-
82 91phoresis are similar to those described for rats 9 and for the
92responsive C57 Bl/10 mouse strain . No changes in skin microsomes 
from control or pretreated rats and hairless mice were v is ib le . This
could be due to insuffic ient sensitivity of the method or because no
change in protein levels occurred. Hepatic AHH induction has been
107 272shown to have requirements for RNA and protein synthesis 9 .
That new and different hepatic apoproteins have been formed after
pretreatments by various compounds has been shown by the purification
and subsequent biochemical and immunological characterization of these 
170 231proteins ’ .A n  alternative way of increasing activ ity  is  by 
activation of already preformed protein. I t  has been shown that 
incubation of haemin with microsomes from various extrahepatic tissues 
from the ra t, rabbit, and chicken increases AHH ac tiv ity , with rabbit 
testes up to 4 1 - fo ld ^ a . This suggests that a pool of apoprotein without 
haem may exist. The effect of haemin on skin monooxygenase activ ities  
has not been investigated. In liverimicrosomes, additional haemin
c n
fa iled to increase cytochrome P-450 levels and only s lightly  enhanced 
AHH^ and ethyl morphine demethyl ase^. Whether the increase in skin 
monooxygenase activ ities  a fter pretreatment is due to de novo synthesis 
of haemoprotein or activation of preformed protein w ill have to await 
further investigation.
5.3.2 NADPH Cytochrome C Reductase
The non-linearity of NADPH cytochrome c reductase activ ity  with protein 
was not due to loss of the prosthetic flavin groups, as shown by the 
lack of effect of supplementation of FAD and FMN to the incubations.
I t  was considered that this phenomenon could be due to aggregation of 
the microsomes increasing with increasing protein concentration, and 
as cytochrome c is a large molecule i t  may be obstructed from the 
active site of the enzyme. To investigate th is , pottasium ferricyanide, 
a much smaller molecule, was used as an alternative electron acceptor. 
However, the background non-enzymic rate was so high, compared with the
increase due to the enzyme, that accurate measurement could not be 
made.
The monitoring of NADPH utiliza tio n  showed that alternative metabolism
of NADPH was not the cause of the non-linearity. This study did raise
some questions in that the stoichiafometry of moles NADPH oxidized was
1:1 with moles of cytochrome c reduced. This is not the ratio  expected
as NADPH is a two electron donor and cytochrome c is a one electron
acceptor. The reaction catalysed by hepatic NADPH cytochrome c reductase
176has a stoichiometry of 2:1 . The endogenous rate of NADPH oxidation
may have accounted for th is , but i f  this is the case then the endogenous
rate must have exhibited the same non-linearity as cytochrome c reduction
since the stoichiometry was constant at different protein concentrations.
I t  is possible that this stoichiometry reflects a true difference from
the hepatic reductase. We were not able to fu lly  investigate whether
this reaction was carried out by the enzyme corresponding to that found
in liv e r, because there are no good specific inhibitors of this reaction,
except the specific antibody raised against the purified protein, which
was- not available. Values quoted in the literature  for cutaneous NADPH
215cytochrome c reductase have been 7.9 nmol/min/mg protein for mouse
16f)and 4.5 nmol/min/mg protein for rat . Linearity, or otherwise, with 
protein was not mentioned in either of these reports.
5.3.3 Inhibition
The effects of metapyrone and 7,8-benzoflavone on rat hepatic
vc
7-ethoxycoumarin metabolism hasebeen investigated by several workers.
-5Metyrapone at 2x10 M inhibited the activ ity  from control hepatic
microsomes approximately 5.0$ with sensitivity to inhibition increasing
26170% after phenobarbitone induction . Microsomes from 3-methylcholan-
259threne induced animals were insensitive to metyrapone . ‘ Control and
phenobarbitone induced activ ities  were insensitive to 7,8-benzoflavone, but
after 3-methyl cholanthrene inductfoTi :5xl0"^M 7:98-ben*2ofTavohe .inhibited by
40%2^ . -In the present study i t  was observed that both ratrand hairless mouse
skin 7-ethoxycoumarin deethylase a c tiv ities , control or induced, were
equally sensitive to 5,6-benzoflavone and 7,8-benzoflavone. In rat
liver 7,8-benzoflavone has been shown to be a more potent inhibitor
273of AHH than 5,6-benzoflavone . The only major difference between
control and induced preparations was the inhibition shown when either
- f iisomer was employed at a concentration of 1x10 M, the control showing 
less sensitivity than the induced preparations in the hairless mouse.
Both benzoflavone isomers have been reported to inh ib it both control
and induced mouse skin AHH, with the control activ ity  being s lightly  less
sensitive^05*273.
I t  is interesting to speculate as to whether inhibition occurs in vivo
as well as in v itro . Some evidence is obtainable from studies on
polycyclic hydrocarbon induced skin tumourigenesis. Coadministration
of 7,8-benzoflavone with dimethylbenzanthracene decreases the
156 157formation of papillomas ’ . Since benzoflavones act as inducers
as well as inhibitors of cytochrome P-450, the inhibition of
tumourigenesis might have been caused by induction rather than inhibition.
However, when benzanthracene, a strong inducer and weak inh ib itor of
AHH, was administered simultaneously with dimethylbenzanthracene, no
105significant effect on tumour formation was detected . The simultaneous
topical application of 7,8-benzoflavone with dimethyl benzanthracene
decreased the covalent binding of the carcinogen to protein and nucleic 
156 157acids in skin * . Since covalent binding of polycyclic hydrocarbons
depends on activation by the microsomal enzyme complex^02 9 these 
observations suggest that 7,8-benzoflavone does in fact inh ib it the 
metabolic activation of the carcinogenic hydrocarbon in Vivo.
The benzoflavones do not always have a similar effect on tumourigenesis
7,8-Benzoflavone did not inh ib it benzo(a)pyrene induced skin tumouri- 
157genesis but increased the incidenfeof 1,2,5,6-dibenzanthracene-
35induced tumourigenesis . Application of 5,6-benzoflavone 3 days
prior to application of benzo(a)pyrene reduced skin tumour formation 
267by more than 50% . From these observations i t  can be seen that the
effects of the benzoflavones in vivo on polyaromatic hydrocarbon 
carcinogens are not easily interpretable and further studies on the 
benzoflavones in vitro may help to explain them.
The effect of metyrapone is greater than would be expected on the
basis of the situation in liv e r , where sensitivity to 7,8-benzoflavone
259 261appears to preclude sensitivity to metyrapone 9 . Metyrapone
inhibition of 7-ethoxycoumarin deethylation has been reported in 
microsomes prepared from the skin of rats with hexachlorobenzene- 
induced experimental porphyria^0 . Unfortunately the concentration 
of inhibitor used in this study was not reported. The simultaneous 
sensitivity to metyrapone and the benzoflavones in skin indicates a 
major difference in the mixed function oxidases present when compared 
with liv e r.
A clear difference between rat and mouse skin activ ities was shown in 
the response to water soluble solvents. Inhibition of 7-ethoxycoumarin 
deethylase by short chain alcohols has been shown in rat liver"*, 
mouse liv e r2^  and rat in te s tin e ^  and by tetrahydrofuran in rat 
liv e r2^  and s k in ^ .  One study employing 12 different water soluble
solvents showed that hepatic 7-ethoxycoumarin deethylase was sensitive
to a ll of them1. Skin AHH has been shown to be insensitive to
273 41 273ethanol in the mouse and to DMSO in the rat and mouse . This
shows an apparent difference between mouse skin AHH and 7-ethoxycoumarin
deethylase. However, care must be taken when interpreting data from
investigations of solvent inhibition of AHH, since solvent concentrations
273 1such as 1 M methanol or 340 mM acetone have to be used of necessity
as a way of introducing the substrate. Therefore only the effect o f
solvents added over and above these levels have been studied. In cases
where AHH has been reported as solvent insensitive the supposed controls
may be already maximally inhibited by the solvent present.
C H A P T E R  6
NON-OXIDATIVE DRUG METABOLISM IN SUBCELLULAR FRACTIONS OF SKIN AND THE 
DISTRIBUTION OF DRUG METABOLIZING ACTIVITIES BETWEEN THE DERMIS AND
EPIDERMIS
6 .1  INTRODUCTION
Other enzyme systems, apart from oxidative ones, are important in drug 
metabolism. This chapter w ill describe an investigation of two of them 
in skin, namely, one phase 1 ac tiv ity , indoxyl acetate esterase and one 
phase 2 ac tiv ity , glucuronyltransferase. Also the distribution between 
the dermis and epidermis of these enzymes, plus oxidative and 
glutathione-s-transferase activ ity  were investigated.
Conjugation reactions in skin have been largely ignored, yet an 
understanding of how an organ can handle a compound cannot be gained 
by examination of phase 1 metabolism alone. The importance of conjug­
ation reactions can be seen by comparing the metabolic fate of xenobiotics 
which form active metabolites, in microsomes and isolated cells . When 
using hepatic microsomes as the activating system of benzo(a)pyrene, 
the major hydrocarbon metabolite-DNA adduct formed is due to metabolic 
activation of 9-hydroxybenzo(a)pyrene. In contrast when using isolated 
hepatocytes, 9-hydroxybenzo(a)pyrene is conjugated primarily with
glucuronic acid, and the major adduct formed is by further metabolism
12of 7,8-dihydro-7 ,8-dihydrobenzo(a)pyrene . In hepatic microsomes,
N-hydroxyamphetamine and norbenzphetamine in the presence of NADPH
and molecular oxygen give rise to the formation of a cytochrome P-450
product complex. However, this does not occur in isolated hepatocytes
130 131due to rapid glutathione conjugation of the amphetamine metabolites 9
In both these examples, study of oxidative metabolism in isolation gives
a misleading impression of what occurs in vivo. Conjugation is usually
regarded to result in detoxification. This is not always the case as
223glutathione conjugation of 1,2**dichioroethane increases mutagenicity
154while the sulphates of some hydroxyamines react covalently with RNA
155and DNA . Investigation of conjugation is , therefore, important 
in the understanding of the toxicity of foreign compounds.
As discussed in Chapter 3 i t  is not clear whether the distribution  
of esterase activ ity  is real or a r t i f ic ia l .  I f  the activ ities  were 
lysosomal in origin the esterases in the different fractions may be 
expected to have similar characteristics. Therefore, i f  differences 
could be shown to exist between the microsomal and high speed super­
natant a c tiv itie s , i t  would argue against a lysosomal origin. To this 
end these activ ities  were investigated.
The review of the structure of skin in Chapter 1 shows that i t  is a 
complicated organ, with different layers and specialized appendages.
Drug metabolism activ ities  would not, therefore, be expected to 
be equally spread throughout the skin and i t  would be of great 
interest to find which are the major local sites of the various 
a c tiv ities . However, the a b ility  to investigate this is severely 
curtailed by lack of suitable methodology. For example, the total 
amount of sweat glands in the human body may be considerable, but 
individually they are very small and d if f ic u lt  to isolate. Histochemical 
investigation would overcome many problems, but the lack of suitable 
assays, except for the esterases, lim its this approach. The easiest 
method is a crude s p lit between the epidermis and dermis, although the 
fraction obtained which is called the dermis usually contains many 
appendages of epidermal origin. Although simple in design this 
approach can give rise to useful information and was used in this 
investigation.
6 . 2  RESULTS
6.2.1 UDP-Glucuronyltransferase
Figures 6.1 and 6.2 show the results of investigation of the effect 
of concentration of the detergent B rij 35, a glucuronyltransferase 
activator in liv e r, on the rate of conjugation of 1-naphthol. The 
greatest enhancement of ac tiv ity  in rat skin was observed at a 
detergent to protein ratio of 0.4 . Above this there was a sharp drop 
in conjugation activ ity  such that at a ratio  of 1.48 inhibition of 
over 30% was observed. Maximum activation of hairless mouse cutaneous 
glucuronyltransferase was observed at approximately the same detergent 
to protein ratio as in the ra t. In contrast to the ra t, however, as 
the detergent to protein ratio was further increased, the ac tiv ity  
dropped much more gradually. At the highest ratio measured, 1.34, 
there was s t i l l  a 27% enhancement over control.
The effect of a variety of compounds on both native and activated 
glucuronyltransferase, using 1-naphthol as substrate, were investigated. 
The results are summarized in Table 6.1. Magnesium chloride had no 
effect on the hairless mouse a c tiv itie s , but enhanced the ra t ac tiv ities  
30% in the native and 10% in the activated preparations. EDTA and ATP 
had l i t t l e  effect on the rat activ ities  and were slightly inhibitory  
in the hairless mouse samples, both native and activated. Saccharic 
acid-1,4-lactone had no effect on any of the samples. The two solvents 
DMF and DMSO had no effect in rat. but in hairless mouse samples DMF, 
but not DMSO, caused a slight enhancement in native a c tiv ities .
The kinetics of glucuronidation of 1-naphthol in the rat and hairless 
mouse were investigated, and the results are shown in Table 6.2 and
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Figures 6.3 and 6.4. I t  must be stressed that values calculated for 
the kinetic constants are apparent values and were measured by keeping 
the value of UDPGA constant while the concentration of 1-naphthol 
was varied. As glucuronide formation is a two substrate reaction, 
to estimate the real Km and Vmax of 1-naphthol, the experiment should 
have been carried out for a range of UDPGA concentrations.
The apparent Km for the rat increased from 9.6 to 18.5 jliM  upon addition 
of Brij 35. Native preparations exhibited substrate inhibition at 
concentrations of 1-naphthol above 20 jliM . This was not observed in 
activated preparations, which had linear double reciprocal plots 
(Figure 6 .3 ).
Activity in the hairless mouse exhibited a biphasic response to the 
concentration of 1-naphthol. There were no significant differences 
between the apparent Km's for 1-naphthol between native and activated 
preparations. In a ll activated preparations, both rat and hairless 
mouse, there was, as expected, an increase in Vmax compared with 
native preparations.
Table 6.3 shows the results of intraperitoneal pretreatment of rats 
and hairless mice with 3-methylcholanthrene on 1-naphthol glucuronidation. 
All preparations showed some increase, the largest when native microsomes 
were used (146% and 180% for the native rat and hairless mouse and 
122% and 146% for the activated rat and hairless mouse). These increases 
were rather small and only the increase in the activated hairless mouse 
preparations was s ta tis tic a lly  significant.
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Corn Oil 3-Methylcholanthrene Percentage
of Control
Native 2.3±0.2
Rat
Activated 5.4+0.6 
Hairless Native 1.0±0.2
Mouse Activated 2.6+0.3
TABLE 6.3
Effect of Intraperitoneal Administration of 3-Methylcholanthrene on
UDP-Glucuronyltransferase in Skin Microsomes
Results are expressed as mean and standard deviation of three
f
experiments. p<0.05.
3 .0±0.3 
6 .6 ± 0 .4 ^  
1 .8 ± 0 .3 :t  
3 .8 + 0 .3 ^
130
122
180
146
6.2.2 Indoxyl acetate esterase
Figure 6.5 shows the relationship between pH and activ ity  of indoxyl- 
acetate esterase activ ity  from microsomesand high speed supernatants 
from rat and hairless mouse skin. All preparations showed a broadly 
similar response to pH, with optima between pH 7.0 to 8.0. The optima 
in the rat were at a slightly lower pH than those in the hairless mouse 
preparations. Activity was very low at pH 5.0 and at pH 4.0 ac tiv ity  
was only detectable in rat microsomes.
The results of an investigation into the kinetics of the esterase 
activ ities  are shown in.Table 6.4. The apparent Km's in the ra t are 
similar in the microsomes and supernatant, being 501 jliM  and 503 
respectively. The hairless mouse exhibited a difference between the 
Kml!s in the two fractions, the Km in microsomes (834 jiM) being about
double that calculated for the supernatant (416 jjM) .
The effect of various compounds on the esterase activ ities  were
-3investigated. The compounds were eserine (5x10 M), £-chloromercuri-
benzoate (5xN f5 M), EDTA (5x1Cf3 M) and CaCl2 (5xl0‘ 3 M). No effect 
was observed in any of the preparations. Furthermore, pretreatment 
by intraperitoneal administration of rats or hairless mice with
3-methylcholanthrene had no effect on either the microsomal or super­
natant ac tiv ities .
6.2.3 Distribution of enzyme activ ities
The supernatant after centrifuging at 8,000 g for 20 min was used as
the enzyme source for a ll assays in this study. The epidermis was
separated from the dermis by methods described in Chapter 2. The
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FIGURE 6.5
Relationships between pH and indoxyl acetate esterase activ ity  in 
microsomes and high speed supernatant in (a) ra t, and (b) hairless 
mice. pH 4.0 and 5.0, c itrate  buffers; pH 6.0 c itrate phosphate 
buffer; pH 7.0 and 8.0, phosphate buffers.
•  microsomes 
▼ supernatant
Km Vmax
nmol /mi n/mg protei n
Microsomes 501+35 419+35
Rat
Supernatant 583+80 66±16
Hairless Microsomes 834±34 366+34
Mouse Supernatant 416+20 58+7
TABLE 6.4
Apparent Kinetic Constants of Indoxyl Acetate Esterase in Skin 
Subcellular Fractions
Results are expressed as mean and standard deviation of three 
experiments.
results obtained are shown in Tables 6.5 and 6.6. In the hairless 
mouse the highest specific activ ities  for the esterase, glutathione-S- 
transferase and glucuronyltransferase were obtained with the dermal 
samples. Only 7-ethoxycoumarin deethylase showed a higher ac tiv ity  
in the epidermis. In the ra t a ll four reactions had higher specific 
activ ities  in the dermal samples. 7-Ethoxycoumarin deethylase in the 
rat was assayed after pretreatment of 3-methylcholanthrene administered 
intraperitoneally. All other activ ities  were measured from untreated 
animals. The ratio of specific ac tiv ity  in the dermis and epidermis 
for the esterase and glutathione-S-transferase were roughly sim ilar in 
both ra t and mouse preparations. The glucuronyltransferase activ ity  
was much higher in the dermis relative to the epidermis in the rat 
than in the hairless mouse.
6.3 DISCUSSION
6.3.1 UDP-Glucuronyltransferase
As found in liv e r, latency of glucuronyltransferase was observed in 
rat and hairless mouse skin microsomes. Activation of hepatic glucuronyl­
transferase can be achieved by a number of treatments, such as addition
86of surfactants, proteases, phospholipases or by storage . Activation 
is thought to be due to perturbation of the endoplasmic reticulum, 
resulting in an increase in the amount of enzyme available to the substrate. 
Experiments involving partial digestion of hepatic microsomes with 
trypsin have led to the conclusion that the transferase is buried deep 
in the membrane . The maximal increase in activ ity  in this study in 
both rat and hairless mouse was sim ilar, approximately 2-fo ld , but the 
rat showed a greater sensitivity to the ratio of detergent to protein.
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This may well reflec t a difference in the membrane rather than a
difference in the enzyme between the two species. The amount of
activation is small compared to rat live r where, using 1-naphthol as
171substrate, increases of 10-fold with Triton X-100 and 30-fold 
241with Brij 35 have been reported.
The specific activ ity  in native rat skin microsomes, as expressed
on a per mg protein basis, compares favourably with values reported
for rat l i v e r ^ ,  being about half, although i t  decreases to about
one tenth when comparing activated microsomes. I t  cannot be certain
that what is called native skin microsomes have not already been
partia lly  activated. In a previous study i t  has been reported that
digitonin did not activate 4-nitrophenol glucuronidation in a
230preparation derived from epidermal cells . As shown in Chapter 3 
the reason for the small degree of latency in skin may l ie  in the 
preparation rather than in the inherent properties of the enzyme in 
skin.
Investigation into the kinetics of 1-naphthol glucuronidation revealed
differences between the rat and hairless mouse. Native rat skin
microsomes exhibited substrate inhibition which was not apparent
in the activated rat preparations nor in either the native or
activated hairless mouse preparations. Double reciprocal plots of
hairless mouse activ ity  displayed a biphasic response in both native
and activated preparations. A similar biphasic plot has been reported
several times for 4-nitrophenol glucuronidation in native hepatic 
137 280 282microsomes 5 9 , but this was reported to disappear on
activation. The biphasic Lineweaver-Burke plots we obtained could 
be due to the presence of two enzymes that catalyze the same reaction
but having different Km's, or i t  could represent a homotrophic
negative co-operativity e ffect, similar to that described by Levityki 
164and Koshland . This is when a modifier, in this case the substrate, 
binds at an allosteric site on the enzyme, causing a decreased a ffin ity  
at the active site for the substrate. Further investigation is needed 
to reveal which is the correct explanation.
In this study, activation of glucuronyltransferase produces an increase
in Km in the ra t but not in the hairless mouse skin microsomes.
Activation procedures have been shown to have a variety of effects on
the kinetics of hepatic glucuronyltransferase. The Km using
4-nitrophenol as substrate has been reported to be increased on
137activation by UDP-N-acetylglucosamine in the mouse and by phospho-
282 122lipases in the mouse and rat , while a fter detergent activation
171 281in the rat the Km's for 1-naphthol or 2-ami nophenol remained
unchanged. I f  activation just reveals more of the enzyme the Km might
be expected to remain unchanged with only an increase in Vmax. Whether
this change in the kinetic constant appears on activation may well !
depend both on the general state of the membrane as well as the
specific enzyme characteristics.
The Km values for both the rat and hairless mouse skin observed in this
study are much smaller than those quoted for 1-naphthol glucuronidation
in rat liv e r, 410 pM ^ and 100 p M ^ , and small intestine, 73 p M ^ .
These values for liver and small intestine are in the same range as
those quoted for the glucuronidation of other foreign compounds in the 
1Q3liver . Values for Km's in the range of those found for 1-naphthol
in skin have also been quoted for the glucuronidation of some steroids.
226Thus Km's of less than 15 pM have been described for testosterone
o p r  ??/ !
and oestriol in human liv e r and oestrone in rat liv e r. As no 
other kinetic data is available for skin glucuronyltransferase, i t  is 
uncertain whether this apparent high a ffin ity  for the substrate is 
typical or is peculiar to 1-naphthol. I f  the la tte r  was true i t  would 
raise the interesting possibility that 1-naphthol was mimicking an 
endogenous substrate.
Pretreatment with 3-methylcholanthrene resulted in a tendency to 
increase 1-naphthol glucuronidation activ ity  in both ra t and hairless 
mouse skin. That the greater increase was observed in native microsomes 
is the reverse of the situation after induction of hepatic glucuronyl­
transferase where increased activ ity  appeared to be most evident i f
191a perturbant was present during the assay after phenobarbitone or
2643-methylcholanthrene pretreatment. I t  is uncertain as to whether
the small increase in activ ity  in the skin preparations was due to
induction or some kind of activation. There has only been one previous
report on the effect of pretreatment on glucuronyltransferase in skin.
Topical application of benzo(a)pyrene was found to increase 2-amino-
87phenol glucuronidation 80% in mouse skin .
I t  is possible that the rate of glucuronidation in microsomes can be
affected by the presence of other enzymes such as UDP-glucuronic acid
pyrophosphatase and 3-glucuronidase. UDPGA has been reported to be
214rapidly broken down in skin homogenates so UDP-glucuronic acid 
pyrophosphatase may be present in the preparation. EDTA and ATP
OOCa
have been shown to be inhibitors of this pyrophosphatase .
Addition of these compounds to skin incubations had no effect on rat 
and a s lightly  inhibitory effect on hairless mouse skin glucuronidation 
of 1-naphthol. Saccharic acid-1,4-lactone, an inhibitor of 3-glucuronidase,
has been reported to increase the formation of the glucuronide of
245indoacrylic acid in ra t hepatic microsomes . The results from the 
subcellular distribution studies (Chapter 3) showed considerable 
contamination of the microsomes with acid phosphatase and so they may 
also contain a significant amount of lysosomal 3-glucuronidase. However, 
addition of saccharic acid-1,4-lactone had no effect on glucuronidation 
at pH 7.6 by rat or hairless mouse skin microsomes.
The solvents DMF and DMSO were investigated because they were found 
to inh ib it hairless mouse skin microsomal 7-ethoxycoumarin deethylase 
(Chapter 5). The intention of this experiment was to ascertain i f  this 
inhibition was due to a general membrane damaging effect, which would 
either activate or inh ib it glucuronyltransferase. No such activation 
or inhibition occurred except for a slight activation by DMF on hairless 
mouse skin microsomes.
Magnesium is known to increase hepatic glucuronyltransferase ac tiv ity
in both native and activated microsomes^ . However, * .
magnesium has different effects on hepatic glucuronyltransferase
290depending upon the substrate used . In one group of a c tiv itie s ,
as typified by 4-nitrophenol and 2-ami nophenol, magnesium increases
the Vmax only, but in another group, typified by 4-ami nobenzoate,
290magnesium does not effect Vmax but decreases the Km for UDPGA .
In this study magnesium only stimulated activ ity  in the ra t, 
the native microsomes showing the greatest increase (30% 
above controls). Interestingly in liver and gut the glucuronidation 
of 1-naphthol has been reported to be stimulated 30% in activated
241microsomes and to be unaffected in native microsomes by magnesium .
That magnesium had no effect on hairless mouse skin preparations may be due
the presence of endogenous magnesium. I f  this was the case i t  could 
account for the inhibitory effect of EDTA, which would chelate the 
magnesium, on hairless mouse skin glucuronidation.
6.3.2 Indoxyl Acetate Esterase
The pH optima for the activ ities  in the rat and hairless mouise were
similar to that reported for the hydrolysis of indoxyl acetate in rat
241hepatic microsomes, namely pH 8.0 . I f  the activ ities  were of lyso­
somal origin an acid pH optimum would be expected. However, a few 
lysosomal enzymes are active at high pH's such as the activators of
angiotensinogen, plasminogen and kininogen and the enzymes aspartyl-
16glucosylaminase and naphthylamidase . The la tte r  example is of 
particular interest because i t  has been proposed that.some enzymes 
possess both amidase and esterase a c tiv ity ^ . Therefore, no definite  
conclusions can be drawn from this study.
Various inhibitors are useful in investigating which class of esterase 
is responsible for the hydrolysis of a substrate. Eserine inhibits
_r
cholinesterase at 10 f4 and g-esterases at higher concentrations.
£-Chloromercuribenzoate strongly inhibits arylesterase while i t
activates c-esterases at low concentrations. Some arylesterases are 
2+activated by Ca while some are activated by EDTA. However, a ll four 
of these compounds had no effect on any of the esterase ac tiv ities  
in the present study. The insensitivity to p-chloromercuribenzoate 
indicated that the activ ities  are probably not of the arylesterase 
type. No other definite conclusions can be drawn.
Investigation of the kinetics of hydrolysis of indoxyl acetate did not 
show a clear difference between microsomal and supernatant a c tiv itie s .
The Kr in the rat were sim ilar, but in the hairless mouse the Km
in the microsomes was double that in the supernatant. All the
T \  "  '  ‘
apparent Km!Sjcalculated for skin preprations are much higher than
those quoted for rat live r microsomes, 41 pM and rat small 
241intestine, 26 j-iM
These studies could not d ifferentiate clearly between microsomal and high 
speed: supernatants ndoxyl acetate esterase activ ities either in rat or 
hairless mouse skin. Although no conclusions can be drawn as to whether the 
distribution between the fractions is real or a rtifac tu a l, i t  is 
apparent that the activ ities  in skin are very different from those 
found in liv e r.
6.3.3 Distribution of Enzyme Activities
That the hairless mouse epidermal preparation had the highest 7-ethoxy-
coumarin deethylase activ ity  agrees with several reports of mouse AHH
activ ity  being greater in the epidermis^’^ ’^ .  Induction, either by
topical application or intraperitoneal injection, of benzanthracene
275did not change the distribution of AHH . However, the bias towards 
the epidermis in the distribution of AHH activ ity  appears to be greater 
than that seen in this study for 7-ethoxycoumarin deethylase. I t  has 
been reported that histochemical investigation of AHH in mouse skin 
showed activ ity  in the sebaceous glands in control animals, and also
pco
in the epidermis after 5,6-benzoflavone induction . AHH ac tiv ity  
in human skin has also been reported to be mainly located in the 
epidermis^.
The distribution of 7-ethoxycoumarin deethylase in rat skin, as shown 
in this study, exhibits a marked difference from the hairless mouse in
t h a t  t h e  o n l y  d e t e c t a b l e  a c t i v i t y  was i n  t h e  e p i d e r m i s .  The d i s t r i b u t i o n
of AHH activ ity  in rat skin has not been reported, although a histo*-.
chemical study of aniline hydroxylase demonstrated low levels in the
epidermis and hair fo llic le s , with much higher activ ity  in the sebaceous 
113glands . The difference in distribution of cytochrome P-450 
dependent activ ity  in skin between the ra t and mouse could be a 
potentially important species difference, especially in the choice as 
to which may be the most suitable model for human skin in toxicology 
studies.
No investigations of the distribution of esterase activ ity  using cell
free preparations have been described although several histochemical
ID 93 186studies have been reported 9 5  . These showed esterase ac tiv ity
spread through the skin in the epidermis, sebaceous glands and hair 
fo llic le s . This spread of ac tiv ity  agrees with the results in the 
present investigation. No studies of distribution of glutathione-S- 
transferases or glucuronyltransferase activ ity  appear to have been 
undertaken before, although one study has compared the glucuronyl­
transferase activ ity  in a cell line derived from epidermal cells to
230that in fibroblasts . Activity was only detectable in the epidermal 
cells.
There may be a logical reason as to why, as shown iri this study, the 
epidermis has a low conjugation capacity compared to the dermis. 
Conjugation results generally in a more water soluble compound and as 
the epidermis has no blood supply any conjugate formed there would have 
to diffuse through a lip id  environment to be excreted. That the 
distribution of oxidative metabolism in the mouse is the reverse of 
that of conjugation ac tiv ities , would give rise to a poor a b ility  to
detoxify products of oxidative metabolism in the epidermis and may 
contribute to the particular sensitivity of mouse skin to compounds 
such as the polycyclic aromatic hydrocarbons.
The present study also showed considerable activ ity  in the dermal 
layer. Investigations which concentrate on the epidermis alone, 
therefore, could miss significant amounts of skin drug metabolizing 
ac tiv ities . Further study of the distribution of drug metabolizing 
activ ities  in the skin is an area of obvious practical and theoretical 
importance.
C H A P T E R  7 
DRUG METABOLISM IN SKIN STRIPS
7 .1  INTRODUCTION
Many in vitro drug metabolism studies have been undertaken using sub-
cellular fractions. These cell free preparations, however, have a
number of disadvantages when compared to whole cell preparations, such
as, isolated cells , tissue slices, or perfused organs. Some of the
disadvantages of cell free preparations obviated by use of whole cell
preparations are: artefacts arising from the homogenization procedure;
nonphysiological cofactor levels; isolated subcellular fractions w ill
not show up the total metabolism of a drug i f  this metabolism is
carried out through the cooperation of a number of different organelles;
metabolism of a drug is dependent on its  entry into the cell and this
factor cannot be assessed in isolated cell fractions. For the above
reasons metabolism studies using subcellular fraction incubating systems
may misrepresent, both quantitatively and qualita tive ly , the in vivo
situation. Whole cell preparations, however, are also associated
with various disadvantages. As regards the system pertinent to this
study, tissue slices, there is unavoidable damage during preparation.
Necrosis may occur at the centre of the strips due to anoxia. There may
also be problems with diffusion of substrates into the strips. The
levels of substrates may have to be lower than those used in cell free
preparations due to cytotoxicity, for example, the concentration of
biphenyl normally used in microsomal assays is toxic to isolated 
96hepatocytes . These factors must be considered when using such a 
technique.
Previous uses of skin strips are shown in Table 7.1. Only one deals with 
a drug metabolizing ac tiv ity , UDP-glucuronyltransferase. Most of 
these studies were of a qualitative nature only. Skin strips are
Topic of Investigation Reference
14C Acetate Incorporation 114, 115, 166,
Respiration Studies 52, 73, 108
Amino Acid Metabolism 18
Androgen Metabolism 239
2-Aminophenol Glucuronidation 248
TABLE 7.1
Previous Uses of Skin Strips
potentially a useful tool for investigating drug metabolism, and in 
this study were used to investigate, qualitatively and quantitatively, 
oxidative and subsequent conjugation reactions.
7.2 RESULTS
The products of metabolism of 7-ethoxycoumarin by hairless mouse skin 
strips are shown in Figure 7.1. With rat skin strips, after one hour 
incubation with 7-ethoxycoumarin, only the glucuronide was detectable, 
the specific activ ity  of which was 0.11±0.03 nmol/100 mg dry weight/hr.
The glucuronide was also the major metabolite in the hairless mouse 
preparation; 61% after one hour. More free metabolite than sulphate 
was found in the f ir s t  forty minutes, but the position reversed after  
one hour incubation with the sulphate accounting for 22% and 7-hydroxy- 
coumarin for 17% of the total metabolites. The metabolism of 7-ethoxy- 
coumarin in hairless mouse strips was 34 times greater than that detected 
in the ra t. Incubation of rat and hairless mouse strips with biphenyl 
led to no detectable metabolism after one hours incubation.
When 7-hydroxycoumarin was incubated with strips from either species 
the pattern of metabolism was sim ilar, as shown in Figures 7.2 and 7.3.
After one hour incubation the percentages of the total metabolites 
of the two conjugates were, in the rat 89% glucuronide and 11% sulphate, 
and in the hairless mouse 93% glucuronide and 7% sulphate. Because of 
the low amount of sulphate compared to glucuronide, and the sequential 
hydrolysis scheme used for the measurements of the conjugates (Chapter 2 ), 
any carry over of 7-hydroxycoumarin from the glucuronide hydrolysis would 
interfere with assessment of sulphate concentration. This was checked 
by carrying out a parallel hydrolysis with sulphatase, in the presence 
of saccharic acid-1,4-Tactone, without prior hydrolysis with 3-glucuronidase.
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FIGURE 7.1
Pattern of metabolism of 7-ethoxycoumarin by hairless mouse skin strips. 
Activities represent mean of three experiments.
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FIGURE 7.2
Pattern of metabolism of 7-hydroxycoumarin by ra t skin strips. 
Activities represent mean of three experiments.
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FIGURE 7.3
Pattern of metabolism of 7-hydroxycoumarin by hairless mouse skin strips. 
Activities represent mean of three experiments.
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A similar amount of 7-hydroxycoumarin was released in this situation 
to that when the sequential hydrolysis scheme was employed. The 
amount of conjugates formed from 7-ethoxycoumarin by the hairless 
mouse strips was 1.7 times greater than that in ra t strips, showing 
a greater sim ilarity between the two species in conjugation capacity 
than in the a b ility  to deethylate 7-ethoxycoumarin. In contrast to 
the above findings, incubation of 2-nydroxybiphenyl or 4-hydroxybiphenyl 
with rat skin strips resulted in no detectable metabolism a fter  ^
incubation for one hour.
Table 7.2 shows the effect of various pretreatments on 7-ethoxycoumarin 
metabolism. The data represent the to ta l metabolites formed after  
incubation for one hour. The rat exhibited the greater responsiveness 
to the compounds used. Intraperitoneal administration of 5,6-benzoflavone 
and 3-methylcholanthrene resulted in a 33 and 24-fold increase in 
deethylation respectively. In rats topical application of 5,6-benzo- 
flavone was less effective, with a 29 fold increase over the acetone 
control'.
The hairless mouse showed a different pattern of induction when 
comparing the different routes of administration. Topical application 
of 5,6-benzoflavone was most effective with a 10-fold increase, 
whereas intraperitoneal administration resulted in a 4-fold increase. 
3-Methylcholanthrene was again the poorest inducer with a 2-fold  
increase.
Because of the greater responsiveness of the ra t, induction dramatically 
decreased the difference between the a b ilitie s  of the two species to 
deethylate 7-ethoxycoumarin. Activity in the hairless 
mouse was 2-fold greater than in the rat a fter topical 5,6-benzoflavone

induction, and 7-fold greater after intraperitoneal administration of 
the same compound.
Figure 7.4 shows the results of investigation of the nature of the 
metabolites formed by rat skin strips after intraperitoneal administration 
of 5,6-benzoflavone. Major differences were observed compared to the 
metabolite pattern in the untreated ra t, in which only the glucuronide 
was detectable. 7-Hydroxycoumarin contributed the largest proportion 
of the total metabolites (42%) after one hour incubatfoo, while the 
glucuronide and sulphate accounted for 38% and 20% respectively.
Differences in the metabolite patterns were also apparent a fter  
intraperitoneal and topical administration of 5,6-benzoflavone to 
the hairless mouse, as shown in Figures 7.5 and 7.6. In both cases 
the percentage of free metabolite detected was much greater than in 
untreated animals. The amount of sulphate found was again small, 
with activ ities  just s lightly larger than those found in strips 
prepared from untreated animals. Therefore, in vivo administration 
of 5,6-benzoflavone leads to qualitative and quantitative changes in 
the pattern of 7-ethoxycoumarin metabolites formed by ra t and hairless 
mouse skin strips. The effect of 3-methylcholanthrene pretreatment 
on metabolism of 7-hydroxycoumarin is shown in Table 7.3. No change 
in activ ity  was detectable.
7.3 DISCUSSION
In skin strips, 7-hydroxycoumarin, whether produced by oxidative metabolism 
of 7-ethoxycoumarin or added directly , is metabolized to either the 
sulphate or glucuronide conjugate, the la tte r being the major metabolite.
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FIGURE 7.4
Pattern of metabolism of 7-ethoxycoumarin by rat skin strips from animals 
induced by intraperitoneal administration of 5,6-benzoflavone. Activities  
represent mean of three experiments.
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FIGURE 7.5
Pattern of metabolism of 7-ethoxycoumarin by hairless mouse skin strips 
from animals induced by intraperitoneal administration of 5,6-benzoflavone. 
Activities represent mean of three experiments.
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FIGURE 7.6
Pattern of metabolism of 7-ethoxycoumarin by hairless mouse skin strips 
from animals induced by topical application of 5,6-benzoflavone. 
Activities represent mean of three experiments.
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This appears to be the f ir s t  demonstration of a xenobiotic being 
sulphated in a skin preparation. Table 7.4 compares the percentages 
converted to either metabolite with results obtained from other studies 
of 7-ethoxycoumarin and 7-hydroxycoumarin metabolism in other organs.
The organ showing the greatest s im ilarity to skin is the rat small 
intestine, especially as regards the metabolism of 7-hydroxycoumarin, 
however, i t  differed in the amount of free metabolite formed when 
7-ethoxycoumarin was used as substrate. This s im ilarity may not hold 
with the small intestine in other species, as is shown by the marked 
difference with the guinea pig, in which the sulphate conjugate was by 
far the major metabolite. The relative rates of sulphation and 
glucuronidation in rat liver and kidney are more evenly matched. These 
results show that large differences are to be found between organs 
and species in the conjugation pattern for 7-hydroxycoumarin.
The effect of substrate concentration on conjugation in skin strips can 
be seen by comparison of the experiments where either 7-ethoxycoumarin 
or 7-hydroxycoumarin were used as the original substrates. When 
hairless mouse strips were incubated with 7-ethoxycoumarin, the 7-hydroxy- 
coumarin concentration (both free and conjugated) after one hour was 
approximately 2 jllM . When the 7-hydroxycoumarin concentration was 
increased to 70 jiM, as when i t  was added d irectly , the rate of formation 
of sulphate doubled while that of glucuronide formation increased 4-fo ld . 
In the same comparison with rat strips, where the concentration of 
7-hydroxycoumarin (both free and conjugated) was about 0.25 juM a fter  
one hours incubation with 7-ethoxycoumarin, increasing the concentration 
to 70 jiM led again to a doubling in the amount of sulphate and to a 7-fold  
increase in the amount of glucuronide. Therefore, an increase in 
substrate concentration led to an increase in the percentage of 
glucuronide formed.
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There are a number of possible factors, acting at d ifferent levels, 
that may control the type of conjugate formed. Some of the most obvious
O O C  1
factors are those of species and strain. The guinea pig and hamster
have been reported to have high glucuronyltransferase ac tiv ity  while
277the cat has been reported to have low glucuronyltransferase and the
247pig low sulphotransferase capacities . A good example of strain
differences is shown by the Gunn rat which is deficient in some glucuronyl-
85 289transferase activ ities  5 . Our finding in skin that the amount of
substrate present can affect the nature of the conjugates, with the
glucuronide being preferentially formed at higher substrate concentrations,
37has also been observed in whole body studies and studies on perfused
183 276organs and isolated cells . However, the reverse has been observed
with the conjugation of 7-hydroxycoumarin in isolated intestinal epithelia l 
76cells . In relation to the whole body studies, the effect of dosage
on conjugation patterns has been explained by some investigators to
132 243be due to depletion of inorganic sulphate 9 , but this has been
270disputed by a recent study on phenol conjugation . Sulphate formation
in isolated hepatocytes has been shown to be dependent on extracellu lar 
184asulphate . The medium used in this study contained 120 mg/1 L-cysteine 
and 400 mg/1 MgS0 .^7H20, so sulphate supply should not have been lim iting .
An alternative explanation for the increase in the percentage of glucuronide 
formed at higher doses of substrate is that the Km for sulphation is 
lower than for glucuronidation. This would lead to the saturation of 
the sulphotransferase at a lower concentration than the glucuronyl- 
transferase. This has been shown to be the case in liv e r for some
1 no 286
substrates such as harmol and 4-hydroxy-3-methoxyphenylethanol
238 193However, the Km’s quoted for the sulphation and glucuronidation
of phenol are similar and a simple characterization of Km may not be
sufficient to identify the real cause of the d ifferentia l saturation
o f  t h e  c o n j u g a t i n g  e n zym e s .
The l a c k  o f  d e t e c t a b l e  a m o u n ts  o f  g l u c u r o n i d a t i o n  o f  2 - h y d r o x y b i p h e n y l
and 4-hydroxybiphenyl in rat strips could be attributed to the absence
of the form of glucuronyltransferase carrying out the reaction in
liv e r. The substrates for which glucuronidation has been measurable
in skin, 4-nitrophenol, 2-aminophenol, 3-hydroxybenzo(a)pyrene, 1-naphthol
and 7-hydroxycoumarin a ll belong to either a 3-methylcholanthrene
32inducible group in live r or a developmental group whose hepatic
activ ities  reach adult levels between days 17 and 20 of gestation
279(late-foetal group) . The overlap of substrates in these two groups
279has led to speculation that they are identical . Of the substrates
for which no activ ity  was detectable, bilirubin and 4-hydroxybiphenyl
32are members of a phenobarbitone inducible group in which activ ities
are less than 10% of adult levels on day 20 of gestation (neonatal 
279group) . There is no data as to which group 2-hydroxybiphenyl
279belongs. A lim iting configuration has been proposed , and i f  the 
molecular structure of a substrate fa lls  outside these confines i t  is 
like ly  to belong to the neonatal group. Using these guidelines
2-hydroxybiphenyl would belong to this group. Confirmation, or 
otherwise, that these results are due to the possible deficiency of the 
glucuronyltransferase that metabolizes substrates of the neonatal 
group w ill depend on the use of a wider range of substrates.
In contrast to the results of the effect of 3-methylcholanthrene pre­
treatment on 1-naphthol glucuronidation in microsomes (Chapter 6 ), no 
change was detected after the same pretreatment on 7-hydroxycoumarin 
conjugation in strips. As discussed previously i t  is uncertain as to 
whether the effect shown in microsomes was due to induction or activation. 
The difference between the two preparations could be due to the use of
two different substrates. I f  the increase in 1-naphthol glucuronidation
was due to a form of activation, this could be already fu lly  expressed
in the whole cell preparations from control animals. The rate of
sulphate conjugation in strips was also unaffected by the pretreatment
31in which respect i t  is similar to live r .
The deethylation of 7-ethoxycoumarin was inducible in both ra t and 
hairless mouse strips, with the ra t, as was found in microsomes 
(Chapter 5 ), being the most responsive. The induction in rat strips 
is similar to that in microsomes in respect of the compound and routes 
of administration, although the fold induction in microsomes could not 
be calculated as the control levels were non-detectable. The values 
for induction in hairless mouse strips, when compared to those of 
microsomes, show some differences. In both cases, when using 5,6-benzo- 
flavone as inducer, topical application was more effective than in tra - 
peritoneal administration. The differences are in the fold increases 
over control values. In microsomes 5,6-benzoflavone given topically  
and intraperitoneally resulted in 1.3 and 3.6 fold increases respectively. 
In strips the same inducer when given topically and intraperitoneally  
resulted in 4.3 and 9.8 fold increases respectively, a much greater 
degree of induction than observed in microsomes. In microsomes,
3-methylcholanthrene given intraperitoneally did not change the 
activ ity , but in strips this pretreatment resulted in a 2.0 fold 
increase in ac tiv ity . I t  thus appears that activ ity  after induction 
is not being fu lly  expressed in microsomes. This could be due to 
destruction of cytochrome P-450, possibly due to differing s tab ilitie s  
of induced forms of cytochrome. I t  is also possible that some factor 
needed for fu ll expression of activ ity  is lost during the subfractionation 
procedure. I t  has been shown in liver that some factors in the high
sp e e d  s u p e r n a t a n t  e n h a n c e d  c y to c h ro m e  P -4 5 0  s u p p o r t e d  a c t i v i t i e s  i n
microsomes^9^ .  Possible modes of action of these factors have been
149postulated to be inhibition of lip id  peroxidation or NADPH pyro- 
233phosphatase . I t  is possible that such factors may exist in skin and 
could be lost in microsomal preparation. An alternative reason for the 
apparent non-expression of induction could be due to an artefact of 
preparation. . The distribution of microsomes in the fractions has only 
been investigated in control animals. The physical characteristics
of live r microsomes change after induction with 3-methylcholanthrene,
88as shown by their increased tendency to aggregate . I f  such a change 
occurred in skin i t  could affect the pelleting of the microsomes.
Ideally the subcellular distribution of enzymes should be checked for 
a ll induction schemes used. There are a number of other possible reasons, 
for example, different substrate concentrations were used, and i t  is 
obviously important to investigate this further as the solution of this 
problem may result in an improvement of the microsomal preparation or 
give rise to some interesting revelations on cytochrome P-450 regulation 
in skin.
Following induction of 7-ethoxycoumarin metabolism in strips, 7-hydroxy- 
coumarin constitutes a large portion of the metabolites formed. From 
Figures 7.7 and 7.8 i t  can be seen that a similar occurrence happens
preparations
in rat kidney tdafcte- formation after 3-methyl cholanthrene induction
but not in rat intestinal cells after phenobarbitone induction, in which
nearly a ll the increase in metabolism is accounted for by conjugated
metabolites. During biphenyl metabolism in isolated hepatocytes high
amounts of free 4-hydroxybiphenyl occurred in it ia l ly  a fter phenobarbitone
276or 3-methylcholanthrene induction (but to a lesser extent, when 
calculated as a percentage of total metabolites, than in kidney or skin) 
The levels of 4-hydroxybiphenyl dropped dramatically a fter about 10-15
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FIGURE 7.7
Pattern of metabolism of 7-ethoxycoumarin by kidney tubule fragments 
isolated from control and 3-methylcholanthrene induced rats. From 
Reference 40.
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FIGURE 7.8
Pattern of metabolism of 7-ethoxycoumarin by intestinal cells isolated 
from control and phenobarbitone induced rats. From Reference 40.
•  Free metabolite, control cells 
o Free metabolite, induced cells 
a Glucuronide, control cells 
a Glucuronide, induced cells
minutes, i t  being mainly converted to the glucuronide. This has been
96ascribed to the free metabolite activating glucuronyltransferase .
This may be the case in the kidney as w ell, where the level of free 
7-hydroxycoumarin was dropping after one hour incubation. In skin, 
however, in a ll cases after induction the free metabolite, concentration 
was increasing, a lbeit at a slow rate, after one hour'; incubation.
This may reflect absolute deethylation activ ities  of these organs with 
the order of ac tiv ity  being liver>kidney>skin. Therefore, the level of 
free metabolite w ill build up faster in the live r and thence activate 
glucuronyltransferase more quickly than in the preparations from the other 
organs. I t  is uncertain as to how the data from the intestinal cells 
would f i t  into this scheme, unless the glucuronyltransferase was already 
activated. I t  is also doubtful as to what extent this reflects the in 
vivo situation where i t  would be expected that the free metabolite 
would be cleared by the blood supply, and not le f t  to build up for 
half an hour and so enable i t  to activate the conjugation system.
An alternative explanation for the presence of a large amount of 
unconjugated metabolite after induction in skin strips is that, as 
discussed in Chapter 6, the major sitesl of oxidative metabolism and 
glucuronidation in the skin may be different. This could well lead to 
a significant amount of 7-hydroxycoumarin remaining unconjugated. I t  
has been established that ly tic  enzymes are released into the medium 
from the strips (Chapter 2). These levels were checked after induction 
and were found to be unchanged. Whatever the reason for the increased 
percentage of unconjugated metabolites formed by induced preparations, 
i t  may have important toxicological consequences as the phase I metabolites 
of many compounds are biologically active.
The rate of 7-ethoxycoumarin metabolism, expressed per gram wet weight 
of tissue, was calculated in hairless mouse skin homogenates from
untreated animals. The rate of metabolism was 6.2+1.5 nmol/hour/gm 
wet weight. Assuming that wet weight for the strips was three times 
the dry weight, the rate of 7-ethoxycoumarin deethylation in control 
hairless mouse skin strips is approximately 9 nmol/hour/gm wet weight. 
As the homogenization of the skin was probably not W&%9 the values 
of microsomal and skin strip activ ities  are quite close arid would 
infer that the cytochrome P-450 monooxygenase system that supports this 
activ ity  is not extensively damaged by homogenization.
In conclusion, skin strips can be used for investigation of oxidative 
and subsequent conjugation reactions. They are a useful preparation 
to be used in conjunction with subcellular fraction studies and may 
well reflect the in vivo situation more closely than the cell free 
preparation.
C H A P T E R  8 
FINAL DISCUSSION
The in it ia l  work in this investigation, which was concerned with the 
efficiency of homogenization, showed that although skin is a tough and 
pliable tissue, excessive disruption is not necessary and can result 
in damage to enzymes and subcellular organelles. Rat skin appeared 
to be more susceptible to damage during homogenization, indicating that 
care must be taken when transferring techniques developed for one 
species to another. Once homogenized a subcellular fractionation scheme
was employed, with which a microsomal fraction was prepared. This
s
fraction contained at least half the whole homogenates ac tiv ity  of 
glucuronyltransferase, which was employed as a microsomal marker.
Studies with other enzyme markers showed contamination by both 
mitochondria and lysosomes. The percentage of lysosomal contamination, 
while being considerable, 15-20$, compares favourably with the 
contamination of hepatic microsomal fractions with lysosomes. The 
contamination of the skin microsomes with mitochondrial material did 
not appear to interfere with attempts to measure cytochrome P-450 
spectrally, although the microsomes used for spectral measurement 
were washed while those for the subcellular distribution studies were 
not.
One question that remains unresolved is that of whether there is 
degradation of cytochrome P-450 during preparation of subcellular 
fractions. A number of observations suggest that degradation does 
not occur, these are: addition of compounds known to protect hepatic 
cytochrome P-450 did not increase cutaneous cytochrome P-450 ac tiv ity ; 
no degradation of hepatic cytochrome P-450 could be detected on mixing 
with skin preparations; levels of cutaneous cytochrome.P-450 activ ities  
were fa ir ly  constant; levels of 7-ethoxycoumarin deethylase in control 
hairless mouse skin homogenates compared well with the levels of the
same activ ity  in control hairless mouse skin strips; the presence of 
unactivated glucuronyltransferase indicated that no major damage occurred 
to the endoplasmic reticulum during homogenization; peaks at 420 nm 
under reducing conditions in the presence of CO could be mainly 
ascribed to the presence of haemoglobin. None of these points, however, 
are conclusive and the question of cutaneous cytochrome P-450 s tab ility  
should be kept under consideration. The difference in the extent of 
induction shown between strips and microsomal preparations posed an 
interesting problem which may be related to in s tab ility  of cytochrome 
P-450. There are other possibilities which have been discussed previously 
(Chapter 7) and are important areas for further investigation.
Cutaneous cytochrome P-450 activ ities  were shown to be inducible and 
to be sensitive to classical inhibitors. I t  was shown that care had to 
be taken with the incubation conditions of rat skin microsomes a fter  
pretreatment with 5,6-benzoflavone, because of apparent inhibition  
by residual amounts of the inducer. This should be recognised in 
future examination of the capability of compounds to induce in the skin.
A number of differences were shown between the cytochrome P-450 activ ities  
in rat and hairless mouse skin. There were quantitative differences, 
with the activ ities  in the mouse being much higher than those found 
in the ra t. The response to inducers was also d ifferen t, with the rat 
being much more responsive. There were also qualitative differences 
shown by inhibition by water-soluble solvents. Of five solvents used, at 
a concentration of 0.1$ v/v, hairless mouse cutaneous 7-ethoxycoumarin 
deethylase was sensitive to a ll of them while the rat was insensitive 
to a ll except ethanol. Differences were also shown in the 
distribution of 7-ethoxycoumarin deethylase between the epidermis and 
dermis. Therefore, there is quite a different pattern of cytochrome
P-450 activ ity  between the two species. I t  would be interesting to 
investigate human skin to see which rodent was the better model.
The inhibition patterns with the benzoflavone isomers and metyrapone 
showed a pattern different to those described in the litera tu re  for 
liv e r. Therefore, different types of cytochrome P-450 may be present 
in skin as compared to the liv e r. Further investigation of the spectral 
properties of the cutaneous cytochrome P-450 would be of great interest, 
especially i f  a reliable quantitation of cytochrome P-450 content 
could be realized. This would enable the calculation of a turnover 
number for the various a c tiv itie s , which would be of greater use when 
comparing skin activ ities  to those in liv e r, or other organs, than a 
specific activ ity  related to protein content.
Glucuronyltransferase activ ity  was shown to be present and, as in liv e r , 
the activ ity  was activated by detergent. The apparent Km for 1-naphthol 
was low in both rat and hairless mouse skin microsomes when compared 
to hepatic values. The significance of these observations w ill have to 
await further kinetic studies with other substrates. The specific 
activ ities  as compared to. those for cytochrome P-450 dependent ac tiv ities  
are much higher, for instance, unactivated glucuronyltransferase ac tiv ity  
to 1-naphthol in hairless mouse skin microsomes is 100-fold higher 
than 7-ethoxycoumarin deethylase ac tiv ity . A comparison of 7-ethoxy- 
coumarin glucuronidation in control hairless mouse skin strips showed 
a greater s im ilarity , with the glucuronidation activ ity  being 10-fold 
higher than the deethylase activ ity . I t  is uncertain whether this 
difference is due to the two types of preparation or the two different 
substrates used for assaying the glucuronyltransferase ac tiv ity .
Conjugation with sulphur was shown to occur in skin. Glutathione-S- 
transferase activ ity  was assayed in cell free preparations and 
sulphation of 7-hydroxycoumarin was assayed in skin strips. These are 
two important drug metabolizing activ ities  and as l i t t l e  more than just 
their presence has been established, further investigation would be 
worthwhile.
The investigation into the esterase activ ity  was made d if f ic u lt  because 
its  subcellular origin could not be unequivocally established. This 
highlights a drawback of the subcellular preparation used. However, 
the skin was shown to possess considerable esterase ac tiv ity .
The investigation of the hair cycle resulted in no change being observed 
in the drug metabolizing activ ities  in contrast with the gross morphological 
changes that were observed in ra t and mouse skin. This gave an indication 
that the hair fo llic le s  may not make a large contribution towards the 
skins capacity to metabolize the substrates used. An interesting line  
of investigation that was not pursued, due to lack of time, was the 
induction of cytochrome P-450 activ ities  at different stages of the 
hair cycle.
Investigation of the distribution of activ ities  between the dermis and 
epidermis raised some interesting questions as to a possible d ifferen tia l 
distribution of oxidation and conjugation activ ities  in the mouse.
This may have some relevance as to why the skin, is sensitive to certain 
compounds, for example some of the polycyclic hydrocarbons, while the 
liv e r, which has the greater metabolizing capacity, is insensitive.
The splitting of epidermis and dermis involved some crude preparations. 
Sophistication of techniques should enable more subtle investigation of
the distribution of ac tiv ities  in the skin. Such studies could well be 
linked with techniques for showing the distribution of foreign compounds 
in the skin.
In most areas of biochemical research, including drug metabolism, skin 
has been largely ignored. Therefore, possible areas of further research 
are almost lim itless. Since the major drug metabolism reactions have 
now been shown to be present in skin, a wider range of substrates 
should be examined to identify qualitatively and quantitatively the 
skins capacity for drug metabolism. A knowledge of which are the 
preferred substrates for the cutaneous enzyme systems could give an 
indication as to the identity of the endogenous substrates for the 
cutaneous drug metabolizing enzymes. Once these are known the true 
role of these enzymes can be gauged.
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